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ABSTRACT 
Linoleic acid isomerase (LAI) is the enzyme that converts linoleic acid to conjugated 
linoleic acids (CLAs) which appear to be capable of lowering cancer risk and enhancing 
immunity. There is an interest in developing commercial processes for the production of single 
isomers of CLA by biotransformation of LA using microbial cells and enzymes. However, the 
evaluation of these strains suggest that growth and LA isomerase production levels by these 
anaerobes are insufficient to support economic commercial production of single CLA isomers. A 
better alternative is to clone the isomerase gene and to generate new production strains using 
recombinant technology. Bifidobacterium LAI genes were cloned into pET24a(+) as an 
expression vector and transferred into E. coli BL21 (DE3) as the expression host while 
Propionibacterium acnes LAI were cloned into Bacillus species as the expression  hosts. 
Unfortunately, the expressed Bifodobacterium LAI formed inclusion bodies and did not exhibit 
detectable enzymatic activities.  Propeptide Staphylococcus hyicus lipase fused with P. acnes 
LAI expressed in B. megaterium YYBm1 was secreted into the surrounding medium. Based on 
MALDI-TOF MS results showed that this propeptide S. hyicus lipase still attached with the 
secreted LAI and might inhibit activity. However, other propeptides (B. subtilis nprE, B. subtilis 
amyE, B. megaterium nprM) did not protect LAI from proteolytic degradation.  
Methionine is the first limiting amino acid in poultry feed and must be supplemented to 
the poultry feed mixture. Many studies attempted to isolate methionine producing 
microoragnisms from environments and genetically modified by using chemical mutagens. 
However, genetically-modified organisms are considered unacceptable for use in organic food 
production.  Therefore, wild type strains with methionine-producing ability are necessary for the 
organic poultry industry. In this study, numerous bacteria were isolated from natural 
environments that appeared to produce high methionine; however, all of them were identified as 
pathogens. In addition, bacteria excreted methionine into the surrounding medium and it was 
concluded that this could be impractical for large scale recovery of methionine. Conversely, 
isolated yeast strain K1 yielded high methionine content, compared to other yeasts. Based on 
large subunit rRNA sequences, these isolated strains were identified as Pichia 
kudriavzevii/Issatchenkia orientalis. P. kudriavzevii/I. orentalis is recognized as a ″generally 
recognized as safe″ (GRAS) organism. Yeast strain K1 may be suitable as a source of 
methionine for dietary supplements in organic poultry feed. 
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CHAPTER ONE  
INTRODUCTION 
 
Gram-positive bacteria appear to be more promising hosts for large-scale production of 
heterologous proteins. Bacillus species are attractive hosts because they possess a naturally high 
secretion capacity, and they export proteins directly into the extracellular medium since the 
cytoplasm of a Gram-positive bacterium is surrounded by a single membrane system (Terpe, 
2006).  For heterologous secretion, proteins also require a targeting signal in the form of a signal 
peptide. The signal sequence is incorporated into the vector at the N-terminus of the target 
protein; however, only some heterologous proteins are successfully secreted. Currently, no 
universal signal peptide is suitable for production of all heterologous proteins (Brockmeier et al., 
2006). Some instances showed that signal peptides alone were not sufficient to secrete proteins 
with complex structures. The propeptide of the S. hyicus lipase appears to prevent the 
degradation of secreted heterologous proteins unrelated to lipase (Meens et al., 1993; 1997; 
Puohiniemi et al., 1992).  
Conjugated linoleic acid (CLA) production is of interest by many researchers since these 
compounds have various biological benefits such as inhibiting the initiation of carcinogenesis 
and tumorigenesis (Pariza et al., 2001; Pariza, 2004).  Linoleic acid isomerases (LAI) found in 
microorganisms catalyze the conversion of linoleic acid to CLA. There is an interest in 
developing commercial processes for the large-scale production of single isomers of CLA by 
biotransformation of LA using microbial cells and enzymes (Kim et al., 2000; Rainio et al., 
2001; Ando et al., 2004). However, the evaluation of these strains suggested that growth and LA 
isomerase production levels by these anaerobes are insufficient to support economic commercial 
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production of single CLA isomers (Peng et al., 2007). A better alternative is to clone the 
isomerase gene and to generate new production strains using recombinant technology. 
Methionine is a nutritionally essential amino acid required in the diet of humans and 
livestock, including poultry. Chickens are unable to produce methionine and therefore must 
obtain it through their diets. Generally, methionine is one of the first limiting amino acids in 
poultry nutrition and typically in most diets this amino acid has to be added to the poultry feed 
(Gomes and Kumar, 2005). Currently, methionine is produced by chemical processes or 
hydrolyzing proteins (Kumar and Gomes, 2005). However, chemical synthesis is expensive and 
produces a mixture of D- and L-methionine. In addition, these processes require hazardous 
chemicals such as acrolein, methyl mercaptan, ammonia, and cyanide (Fong et al., 1981). 
However, methionine from protein hydrolysis must be separated from the complex mixture 
(Kumar and Gomes, 2005). Furthermore, synthetic methionine is currently allowed as an 
additive to organic poultry feed by the U.S. Department of Agriculture’s National Organic 
Program (NOP) however NOP is only extending its use until October 1st 2012 (USDA, 
Agricultural Marketing Service, http://www.paorganic.org/wp-content/uploads/2011/10/USDA-
Methionine.pdf). 
Many studies have attempted to isolate methionine producing microoragnisms from 
environments and genetically modified by using N-methyl-N′-nitro-N-nitrosoguanidine. Several 
studies have reported that methionine-analog resistance in bacterial strains correlated to higher 
methionine production due to an alteration in the regulation of L-methionine biosynthesis 
(Adelberg, 1958; Chattopadhyay et al., 1991; Musilkova and Fencl, 1964;Yamada et al., 1982 
Tani et al., 1988). Although the mutation was successful in generating methionine overproducing 
microorganisms, any genetically-modified organisms are considered unacceptable for use in 
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organic food production.  Therefore, wild type strains with methionine-producing ability are 
necessary for the organic poultry industry.  
The objectives of this research were cloning Bifobacterium LAI into E. coli BL21 (DE3) 
and Propionibacterium acnes LAI in Bacillus species.  For methionine production in 
microorganisms, bacteria and yeasts were isolated from environmental samples and methionine 
contents in these strains were quantified.  
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CHAPTER TWO 
LITERATURE REVIEW 
 
BACTERIAL EXPRESSION SYSTEMS FOR HETEROLOGOUS PROTEIN 
PRODUCTION 
Introduction 
Microbial products continue to be major sources of dietary and health products in the 
daily lives of humans and include products such as vitamin B12, glucose blood test, antibiotics, 
and antivirus medicines.  These products include alcohols from anaerobic metabolism, acids 
from incomplete oxidation, primary and secondary metabolites, enzymes, biocatalysts, and more 
recently, heterologous proteins.  Enzymes produced by microorganisms have been used in food, 
fermentation, textile, paper industries. For example, α-, β-amylases for starch modification have 
been utilized by the baking industry (Eppinger et al., 2011; Vary, 1994).   Schallmey et al. (2004) 
reported that the world market for industrial enzymes was approximately 1.6 billion $ US. For 
the economic production of heterologous proteins, bacterial hosts are usually the systems of 
choice.  
Escherichia coli as host 
Production of specific proteins from original organisms, such as human hormone 
proteins, is impractical at the industrial level and expression hosts serve as possible solutions for 
these problems. Compared to other expression systems, bacteria, particularly Escherichia coli, 
are more favorable because they offer a proven economical route for protein production due to 
their ability to grow rapidly and yield a high density of cells on inexpensive substrates (Terpe, 
2006). In addition, these hosts possess well-characterized genetics that require minimal technical 
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expertise to establish at a laboratory level and eventually on an industrial scale (Zerbs et al., 
2009).  
Among expression systems, E. coli is considered to be the first choice since numerous 
vectors, readily available engineered strains, and minimal technical requirements are already in 
place.  In addition, production of large numbers of cells is rapid due to short doubling times 
(Brondyk, 2009). Although the E. coli system is a well established method for expressing 
bioactive proteins, there are a number of limitations. Posttranslation is essential in  some proteins 
for bioactivity; however, many bacterial systems are not able to modify protein 
posttranslationally. In these cases, bacterial systems should not be used for heterologous 
production (Terpe, 2006). Other disadvantages of protein expression in the cytoplasm of E. coli 
are that these proteins form inclusion bodies and accumulate lipopolysaccharides (LPSs). These 
LPSs are well-known as endotoxins, which are pyrogenic in humans or other mammals (Terpe, 
2006). E. coli also has problems in protein folding and forming disulfide bonds which is 
insufficient for many recombinant proteins (Brondyk, 2009). 
The primary method to minimize inclusion body formation and maximize the formation 
of soluble, properly folded proteins in the cytoplasm is lowering the incubation temperature to 15 
to 30 oC during the expression period (Brondyk, 2009).  The reduced temperature reduces the 
rate of transcription, translation, refolding and thus increases proper folding (Brondyk, 2009). 
Adding a soluble fusion tag at either the N-terminus or C-terminus can promote solubility of 
some recombinant proteins (Brondyk, 2009). 
T7 RNA polymerase system 
One of the most widely used expression systems using E. coli as the host is the T7 RNA 
polymerase system (Table 2.1 and Fig. 2.1) (Terpe, 2006). For protein production, a recombinant 
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plasmid is transferred to an E. coli strain containing a chromosomal copy of the gene for T7 
RNA polymerase. These E. coli hosts are lysogens of bacteriophages DE3, a lambda derivative 
that has the immunity region of phage 21 and carries a DNA fragment containing the lacI gene, 
the lacUV5 promoter, and the gene for T7 RNA polymerase. This fragment is inserted into the 
int gene, preventing DE3 from integrating into or excising from the chromosome without a 
helper phage. Once a DE3 lysogen is formed, the only promoter to direct transcription of the T7 
RNA polymerase gene is the lacUV5 promoter. By a two- point mutation at the -10 region, 
lacUV5 promoter has more promoter strength and less dependence on cyclic AMP and receptor 
protein CAP. In addition, the third point mutation causes this promoter to be less sensitive to 
glucose. Even in the presence of glucose, the expression of this system is induced by addition of 
lactose analog isopropyl-β-D-1-thiolgalactopyranoside (IPTG) to the culture medium or by using 
an autoinduction medium (Terpe, 2006).  
Bacilli as host 
An ideal host should have the ability to secrete large amounts of recombinant proteins 
with only low quantitatives of host proteins and not generate detectable proteolytic activities in 
the supernatant. Because of the endotoxin production and inclusion body formation problems 
associated with Gram-negative bacterium E. coli, Gram-positive bacteria appear to be more 
promising hosts for large-scale production of recombinant proteins. Gram-positive bacteria 
Bacillus subtilis and some of its close relatives are widely used for the industrial production of 
enzymes for the detergents, food, and beverage industries (Eppinger et al., 2011). Bacillus 
species are the dominant bacterial hosts for industrial enzyme producers because B. subtilis and 
B. licheniformis are on the Food and Drug Administration’s GRAS (generally regarded as safe)  
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Fig. 2.1. In this system, plasmids contain a lac operator sequence just downstream of the 
T7 promoter. They also carry the natural promoter and coding sequence for the lac repressor 
(lacI). The T7lac and lacI promoters are divergent. The lac repressor acts both at the lacUV5 
promoter in the E. coli BL21 (DE3) chromosome to repress transcription of the T7 RNA 
polymerase gene by the host polymerase and at the T7lac promoter in the vector to block 
transcription of the target gene by any T7 RNA polymerase that is made (Novagen, pET system 
manual, 11th Edition, 2006). 
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list and some selected strains can secrete large quantities (20 to 25 g/L) of extracellular enzymes 
(Schallmey et al., 2004).  
Intracellular accumulations can lead to problems related to the formation of insoluble 
protein inclusion bodies, incorrect protein folding, and inefficient disulfide bond formation 
(Schallmey et al., 2004). From a commercial point of view, the purification of proteins from the 
culture medium rather than from the cytoplasm is considerably more cost-effective, often leads 
to improved structural authenticity, and reduces the likelihood of the co-purification of 
endotoxins and other potential contaminants (Pohl and Harwood, 2010). For protein secretion, 
most researchers employ Bacillus and related bacteria.  In contrast to Gram negative bacterial 
hosts such as E. coli, Bacillus strains have the general advantage that the outer membrane does 
not possess LPSs. Furthermore, Bacillus spp. are attractive hosts because they possess a naturally 
high secretion capacity, and they export proteins directly into the extracellular medium since the 
cytoplasm of a Gram-positive bacterium is surrounded by a single membrane system, in contrast 
to the double membrane found in Gram-negative bacteria. Gram-positive bacteria have the 
ability to secrete proteins directly into the culture medium at high concentrations.  
Although Bacillus species, compared to E. coli, have many advantages, Bacillus species, 
particularly B. subtilis, secrete proteases which rapidly degrade heterologous proteins (Nijland 
and Kuipers, 2008). By deleting neutral (nprE) and alkaline protease (aprE) genes, B. subtilis 
mutant still retained extracellular protease activity at 4% of the total activity of wild type and 
caused some foreign protein degradation (Wang et al., 1989). To avoid this problem, Wong and 
his colleague developed the extracellular protease negative B. subtilis WB800 strain but 
unfortunately this strain is not commercially available (Table 2.1) (Braaz et al., 2002). In the 
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case of B. megaterium, Wittchen and Meinhardt (1995) deleted the neutral protease nprM gene 
for suitable heterologous expression host.  
Brevibacillus choshinensis 
In contrast to B. subtilis, wild-type Brevibacillus (Bre.) choshinensis (formerly Bacillus 
brevis) produces very low extracellular protease and exhibits high productivity of heterologous 
proteins (Udaka and Yamagata 1993). Bre. choshinensis SP3 has been utilized as a host for 
heterologous expression since this strain has the ability to secrete large amounts of recombinant 
proteins. Currently, Bre. choshinensis SP3 is supplied by Takara, Tokyo, Japan and it has been 
used successfully to produce heterologous proteins that originated from prokaryotic and 
eukaryotic organisms (Table 2.1). By using this strain, Yamagata et al.(1989) produced 0.15 g/L 
of human epidermal growth factor.  
Bacillus megaterium 
B. megaterium is a Gram-positive and non-pathogenic bacterium. Compared to B. 
subtilis, this organism has a number of favorable features as an expression host, including low 
extracellular protease activity, structural and segregational stability of plasmids, and the ability to 
grow on more than 62 carbon sources including waste products from the meat industry and corn 
syrups (Vary, 1994; Vary et al., 2007). B. megaterium, in contrast to B. subtilis, does not possess 
any detectable alkaline proteases that can degrade heterologous products (Bunk et al., 2010). In 
2011 the two genomes of the biotechnologically important B. megaterium QM B1551 and 
DSM319 were completely sequenced (Eppinger et al., 2011). While B. megaterium QM B1551 
carries 7 plasmids, DSM319 is a plasmid-less strain. The chromosome of DSM319 is a circular 
molecule of 5,097,447 bp with an average G+C content of 38.2% and encodes 5272 genes 
(Eppinger et al., 2011).  
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Table 2.1.  Selected bacterial expression hosts. 
Strain  Feature References or Suppliers 
 
E. coli BL21 (DE3) Widely used expression strain which lacks the lon 
and opmT proteases and contains a copy of RNA 
the T7 RNA polymerase gene under the control of 
the lacUV5 promoter. These modifications enable 
stable expression of proteins using T7 promoter 
driven constructs 
 
EMD Millipore 
Corporation, Billerica, 
MA, USA, Novagen, 
Darmstadt, Germany 
E. coli Rosetta-
gami 
K-12 derivatives with mutations in the trxB and 
gor genes which greatly facilitate cytoplasmic 
disulfide bond formation in the cytoplasm. This 
strain enhances the expression of eukaryotic 
proteins that contain codons rarely used in E. coli: 
AUA, AGG, AGA, CGG, CUA, CCC, and GGA 
 
EMD Millipore 
Corporation, Billerica, 
MA, USA, Novagen, 
Darmstadt, Germany 
Bacillus subtilis 
WB800 
 
Extracellular protease-negative strain  Braaz et al.(2002) 
Bacillus 
megaterium 
MS941 
DSM319 derivative with inactivation of the major 
extracellular protease nprM. This strain showed 
only 1.4% of the wild-type total extracellular 
protease activities.  
 
Wittchen and Meinhardt 
(1995), Molecular 
Biotechnology, 
Goettingen, Germany 
Brevibacillus 
choshinensis SP3 
 
Wild-type strain which produces negligible 
amount of extracellular protease.  
Takara, Tokyo, Japan 
Lactococcus lactis 
NZ9000 clpP-htrA 
Strain deficient in both its major proteases, 
intracellular (ClpP) and extracellular (HtrA) 
 
Cortes-Perez et al., 2006 
Staphylococcus 
carnosus 
Wild type strain with complete absence of 
proteolytic activity 
 
Terpe (2006) 
 
 12 
Table 2.2. Selected expression vectors. 
 
Vector 
 
Feature References or Suppliers 
pET series Widely used expression systems for inducible 
expression of protein using a T7 promoter 
construct 
 
EMD Millipore 
Corporation, Billerica, 
MA, USA., Novagen, 
Darmstadt, Gernany 
 
pBAD series Tightly regulated expression systems with 
expression controlled by the presence of arabinose.  
These vectors are wildly used in E. coli, 
Salmonella enterica and related bacteria.  
 
Guzman et al.(1995), 
Invitrogen, Carlsbad, CA, 
USA 
Gateway vectors  A series of vectors that use a  recombinantional 
strategy to enable transfer of DNA fragments 
between different cloning vectors 
 
Invitrogen, Carlsbad, CA, 
USA 
Ligation 
independent 
cloning vectors  
 
A series of vectors that use an anneal strategy to 
enable parallel cloning of coding region fragments  
Aslanidis and de Jong 
(1990) 
pNC series The shuttle vectors between E. coli and B. 
choshinensis containing promoters working in 
Brevibacillus and signal peptides for protein 
secretion   
 
Takara, Tokyo, Japan 
pMM1520 series The shuttle vector between E. coli and Bacillus 
species carrying xylose-inducible promoter.  
Molecular Biotechnology, 
Goettingen, Germany 
 
 
 13 
B. megaterium DSM319 has been shown to be an excellent host for heterologous 
production due to the possession of only one major protease, stability of inserted plasmids, and 
no wild-type plasmids (Vary et al., 2007). To generate DSM319 for heterologous protein 
production, Wittchen and Meinhardt (1995) achieved knockout of the major extracellular 
protease npr M (neutral protease) gene and recovered 1.4% of the extracellular proteolytic 
activity of the wild type and strain MS941 is well suited for extracellular heterologous protein 
production. Unlike B. megaterium, the mutant strain of B. subtilis required deletion of three 
genes (nprE, aprE, and epr) in order to produce approximately 1% of the extracellular 
proteolytic activity of the wild type (Wang et al., 1989). B. megaterium strain MS941 is a 
commercial strain supplied by Molecular Biotechnology (Table 2.1). Strain MS 941 allowed up 
to 1.2 g/L functional proteins to be recovered from the medium (Stammen et al., 2010; Eppinger 
et al., 2011). Inactivation of the xylA gene for xylose metabolism in B. megaterium MS941 led to 
development of the strain YYBm1, which does not require metabolism of the inducer for gene 
activation (Yang et al., 2006).  
The spac promoter 
A widely used system in Bacillus species is the spac promoter (Terpe, 2006). This 
promoter has been constructed by fusing the 5’-sequence of a promoter from the B. subtilis 
phage SPO1 and the 3’-sequence of the E. coli lac promoter including the operator (Pohl and 
Harwood, 2010). The expression of spac promoter is dependent on the inactivation of a 
constitutively expressed lactose repressor LacI by IPTG addition. IPTG is a lactose analog that 
can bind to LacI repressor and then changes LacI conformation to prevent lac promoter binding. 
Finally, RNA polymerase can initiate transcription from phage SPO1 promoter. The spac 
promoter can function in plasmid and chromosomal locations. This system can direct the 
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synthesis of a protein to a significant proportion of total cellular protein. However, this promoter 
is not sufficiently strong and IPTG is too expensive for large-scale fermentation. Based on this 
promoter located in plasmid, Chen et al. (2009) was able to achieve production of 30.6 mg/L of 
cecropin A, a chimeric antimicrobial peptide.  
The xylose-inducible promoter 
Another widely used system in Bacillus species is the xylose-inducible promoter based 
on the XylR repressor (Table 2.1 and 2.2). This promoter originates from B. subtilis and related 
organisms. The xylR-controlled promoter exhibits high levels of expression and has the 
advantage that the inducer xylose is relatively inexpensive (Bunk et al., 2010). The xylA 
promoter is located upstream on the operon coding for xylABT genes (Biedendieck et al., 2010).  
The gene encoding the repressor protein XylR is divergently oriented upstream of the operon 
with the promoter regions of xylR and of the xyl ABT-operon overlapping. In the absence of 
xylose, XylR binds to the two tandem overlapping operator sequences located in xylA promoter 
and prevents transcription of the xylABT-operon. In the presence of xylose, the sugar binds to the 
repressor XylR. This results in a conformational change of XylR which prevents promoter 
binding.  By using this system, the RNA polymerase efficiently recognizes the promoter, and 
gene expression is induced approximately 350-fold. (Vary et al., 2007).  
In 1991, based on a xylose-inducible promoter, Rygus and Hillen (1991) developed 
plasmid pWH1520, which could serve as a shuttle vector between E. coli and B. megaterium. 
Currently, Molecular Biotechnology, Goettingen, Germany, provides the plasmid pMM1520 
series (Table 2.1 and Fig. 2.3) developed from plasmid pWH1520 which allows for the simple 
cloning of target genes by the use of 15 different DNA restriction enzyme cleavage sites (Malten  
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Fig. 2.2. The control elements of the B. megaterim expression vector pMM1520 
(modified from Biedendieck et al., 2010). The xylR gene encodes the xylose repressor protein. 
The xyl operator region is denoted by OLOR indicating the two overlapping binding sites for 
xylR. The first 15 bp of xylA, denoted as xylA’, are fused to a short DNA sequence multiple 
cloning sites (MCS).  
xylR MCS xylA' 
OL OR 
 R   R 
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Fig. 2.3. Structure of the B. megaterium expression vector pMM1520 (Malten et al., 
2005). Elements for xylose-inducible recombinant gene expression in B. megaterium are PxylA 
and the gene encoding the xylose repressor (xylR). Elements for plasmid replication in Bacillus 
are the origin of replication oriU from B. cereus, repU from B. cereus, the tetracycline resistance 
gene (tet) from B. cereus. Elements for plasmid replication in E. coli are the origin of replication 
colE1 from E. coli, the β-lactamase gene (bla) for ampicillin resistance from E. coli.  
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et al., 2005).   It contains the origin of replication colE1 and β-lactamase gene for replication and 
selection in E. coli (Biedendieck et al., 2010). In addition, it carries the origin of replication oriU, 
the repU, and a tetracycline resistance gene for replication and selection in B. megaterium.  The 
expression for secreted heterologous production of these plasmids is based on the xylose-
inducible promoter (Bunk et al., 2010).  Based on this xylose-inducible protein production 
system, novel expression vectors for intra- and extracellular protein production have been 
developed by placing a His6- or Strep II-tag at N or C-terminus and signal peptides (Biedendieck 
et al., 2007).  
Using B. megaterium MS941 with pMM1520 derivative plasmids has proven to be useful 
for efficient secretion of heterologous proteins such as a dextransucrase (DsrS) from 
Leuconostoc mesenteroides, a Lactobacillus reuteri levansucrase (Lev), the B. megaterium 
penicillin G amidase (PGA), and a T. fusca hydrolase (Biedendieck et al., 2007; Malten et al., 
2005, 2006; Yang et al., 2006, 2007). By optimizing codon usage, the promoter region, and the 
ribosome-binding site, Stammen et al. (2010) achieved production of secreted T. fusca hydrolase 
at 7.7 mg/L which is sufficient for commercial purposes.  
Prepeptide or signal peptide 
In general, Bacillus species secrete numerous extracellular homologous proteins with 
their own signal peptides into their surrounding growth medium. Homologous proteins are 
natural proteins from bacterial production. For example, alkaline protease production from B. 
clausii was successful for supplementing into detergents. Conversely, heterologous proteins are 
foreign products from gene transferring from one organism into the other organisms as the 
expression hosts. For heterologous secretion, proteins also require a targeting signal in the form 
of a signal peptide. The signal sequence is incorporated into the vector at the N-terminus of the 
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target protein; however, only some heterologous proteins have been successfully secreted. 
Currently, no universal signal peptide is suitable for production of all heterologous proteins 
(Brockmeier et al., 2006). 
Secretion systems of Bacillus 
In Bacillus species, there are two pathways to secrete proteins across the cytoplasmic 
membrane: Sec-dependent (Sec) and twin-arginine translocation (TAT) (Pohl and Harwood, 
2010). Most studies concentrate on Sec pathway since this pathway is the main route for protein 
secretion. Consequently the current review focuses only on the Sec pathway. The signal peptide 
is the transient extension to the amino terminus of the protein and is removed by enzymes signal 
peptidases. The signal peptides in Sec pathway are usually between 20 to 30 amino acids in 
length, possess a positive charged amino terminal (N) region, which is followed by a 
hydrophobic (H) central region and a short cleavage (C) region containing the target site for 
signal peptidase (Fig. 2.4). After secretion, the signal peptide is removed by Type I signal 
peptidases. The signal peptides have similar consensus cleavage sequences (AXA). The signal 
peptide is removed during the later stages of the process (Harwood and Cranenburgh, 2008). 
Substrate proteins are cleaved by two classes of signal peptidases. Type I signal peptidases 
cleave the most abundant class of secretory substrates.  
In E. coli, the signal recognition particle (SRP) pathway chaperoning or targeting system 
is complemented by the SecB and SecA chaperones that interact with a subset of SRP-
independent secretory proteins. Unlike E. coli, Bacillus species lack a homolog of the secretion-
specific chaperone SecB, and consequently the SPR pathway is the only recognized intracellular 
pathway for presecretory protein recognition, chaperoning, and targeting. The SPR is an RNA-
protein complex that interacts with hydrophobic regions of signal peptides of nascent proteins,  
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Fig. 2.4.  The basic design of Bacillus signal peptides and propeptides. (a). Sec-dependent 
signal peptide cleaved by a Type I signal peptidase (SP); (b) The signal peptide and propeptide 
(prepropeptide) at the N-terminal end of a secretory protein requiring the propeptide for folding 
on the trans side of the cytoplasmic membrane. The signal peptide is removed by a Type I 
enzyme and propeptide either autocatalytically or by a coexisting protease (Harwood and 
Cranenburgh, 2008). 
Type I SP 
H (10-18) N (6) 
~ 30 amino acids 
+ + +      AXA     Propeptide A 
+ + +      AXA A 
~ 30 amino acids 
N (6) H (10-18) 
C 
C 
70-200 
a 
b 
Type I SP Autocatalytic 
NH2- 
NH2- 
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and delivers them to a membrane-bound docking protein (FtsY). Finally the protein complex 
passes the target protein to the secretory translocase (Harwood and Cranenburgh, 2007).  
In Bacillus species, the SRP consists of an RNA molecule that provides the backbone for 
the attachment of two proteins: Ffh and HBsu (Fig. 2.5). The Sec-dependent translocases of B. 
subtilis consists of SecY, SecE, SecG protein to form the core of a heterotrimeric integral 
membrane pore that interacts with SecA, the motor component that drives translocation (Fig.2.6). 
The other functions of SecA work as a chaperone and lead secretory substrates for their site of 
synthesis in the cytoplasm to the Sec translocase. SecDF complex with YrbF is important for 
SecA cycling. Proteins emerge from the Sec-dependent translocase on the trans side of the 
cytoplasmic membrane in a relatively unfolded state. To this end, the secreted proteins are 
rapidly folded, facilitated by a combination of intrinsic and extrinsic factors, such as chaperones 
and folding factors.  
The signal peptides are highly variable, rapid evolving structures (Heijne, 1990). 
Numerous attempts have been made to maximize the secretion of heterologous proteins by 
identifying optimal signal peptides. However, for a specific signal peptide for one target protein, 
it is often found not to be optimal for another. The successful secreted proteins depend on 
characteristics of both the signal peptide and the mature protein; however, this mechanism is not 
fully elucidated (Brockmeier et al., 2006; Nijland and Kuipers, 2008). Therefore, the prediction 
of optimal signal peptides for heterologous protein secretion is difficult and cannot be based 
solely on the signal pepide itself (Nijland and Kuipers, 2008).   
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Fig. 2.5. The structure of the signal-recognition particle of B. subtilis (Harwood and 
Cranenburgh, 2008). Details of the interactions among the components of the SRP, the docking 
protein (FtsY) and the translocase. The SRP is an RNA molecule (small cytoplasmic or scRNA) 
attached with Ffh and HBsu proteins.  
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Fig. 2.6. The structure of the B. subtilis Sec-dependent secretory protein translocase. The 
preprotein substrate is transported through the translocase consisting of the SecA dimmer, 
heterotrimeric pore (SecYEG), the heterotrimeric SecDF-YrbF complex and the main type I 
signal peptidases (SipS and SipT). After translocation, the preprotein is folded into its correct 
formation by propeptides, isomerase and divalent cations as folding factors (Harwood and 
Cranenburgh, 2008). 
.  
 23 
Propeptide 
For heterologous protein production, there are some instances where signal peptides 
alone are considered not sufficient to secrete proteins with complex structures. For example, 
none of the tested signal peptides alone enabled human growth hormone secretion in 
Staphylococcus carnosus (Sturmfels et al., 2001). The protein was found only in strains 
expressing the fusions of human growth hormone with signals and propeptides.   
In Bacillus species, the precursors of some secreted proteins contain propeptides which 
represent significant folding factors. The length and function of propeptides are variable.  The 
cleavable propeptide is part of the precursors of some secreted proteins and is located at the N-
terminal on the primary translation product between a typical signal peptide (prepeptide) and the 
N-terminus of the mature protein (Fig. 2.4) (Sarvas et al., 2004). The length is between 70 to 200 
amino acid residues (Harwood and Cranenburgh, 2007).  Propeptides are not directly involved in 
protein translocation per se but are essential in the post-translational folding required to achieve 
the active and stable form of their cognate secreted protein (Sarvas et al., 2004; Harwood and 
Cranenburgh, 2007). During the secretion of a preproprotein, the signal peptide is cleaved in the 
usual manner during or immediately after translocation. Only after the proteolytic self-cleavage 
and degradation of the propeptide, is full enzymatic activity achieved.  
The roles of propeptide of serine proteases are to provide intermediate complex stability 
as intramolecular chaperones and nucleus generation for the completion of the folding pathway 
(Sarvas et al., 2004). This accelerates folding of proteins. In the absence of propeptides, serine 
proteases do not fold properly and cannot be secreted. In addition, it forms a stable molten 
globule-like folding intermediate during folding. The propeptide binds to the corresponding 
preprotein and guides or catalyses its rapid folding by stabilizing the secondary structure at the 
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site of binding, thereby generating a nucleus for folding. In addition, the other role of propeptides 
of serine proteases is as a proteolytic inhibitor. During the final step in the folding of a protease, 
propeptides are removed autocatalytically by a proenzyme. Degradation of the propeptide 
maintains enzymatic stability and protease-resistant conformation; finally this degradation 
facilitates the release of an enzymatically active form.   
Demleitner and Gotz (1994) demonstrated that N- terminal region of prepropeptide 
region originating from Staphylococcus hyicus lipase was important for lipase activity while the 
C-terminal portion assisted lipase secretion and proteolytic stability. Compared to serine protease 
propeptides removed by proteolytic self-cleavage, the S. hyicus lipase propeptide is degraded by 
a metalloprotease (Sarvas et al., 2004). The lipase propeptide plays a role both in secretion and 
its post-translocational stability.  By deleting the propeptide, the rate of secretion decreases and 
the enzyme remains inactive. Surprisingly, the propeptide of the S. hyicus lipase prevented the 
degradation of secreted heterologous proteins unrelated to lipase. For example, the S. hyicus 
lipase propeptide protected the E. coli outer membrane protein OmpA, against degradation when 
expressed in S. carnosus or B. subtilis (Meens et al., 1993; 1997; Puohiniemi et al., 1992). This 
pattern of production was dramatically altered by extending the N-terminus of OmpA with the 
propeptide of S. hyicus lipase which significantly increased the amount of OmpA in the culture 
medium with little or no evidence of degradation products (Meens et al., 1997). The absence of 
degradation reflects the physiological function of the propeptide. Meens et al. (1997) concluded 
that the propeptide facilitates the release of unfolded proteins from the translocase and/or 
passage through the cell wall, protecting them from proteases at the membrane-cell wall 
interface.  
 25 
A very different conclusion was drawn from studies by Sturmfels et al. (2001). Fusion of 
various staphylococcal propeptides to human growth hormone appeared to maintain the 
proprotein in a secretion competent form in the cytoplasm before engagement with the 
translocase. Since the propeptide of S. hyicus lipase is cleaved by extracellular proteases in the 
natural host strain, in some recombinant proteins, the propeptide still remained fused with the 
mature proteins due to the absence of proteolytic activity in the expression hosts.  
In conclusion, the bacterial systems provide rapid expression methods (days), 
inexpensive bioproduction media, high density biomass, simple process to scale-up, and minimal 
technical requirements (Brondyk, 2009). In spite of these advantages, bacterial systems have a 
number of important limitations for expression of heterologous proteins that should be 
considered, particularly eukaryotic proteins such as chaperones and post-translational 
modification proteins (Terpe, 2006). 
LINOLEIC ACID ISOMERASE 
There is an interest in developing commercial processes for the production of single 
isomers of conjugated linoleic acid (CLA) by biotransformation of LA using microbial cells and 
enzymes (Kim et al., 2000; Rainio et al., 2001; Ando et al., 2004). However, the evaluation of 
these strains suggested that growth and LA isomerase production levels by these anaerobes are 
insufficient to support economic commercial production of single CLA isomers (Peng et al., 
2007).  A better alternative is to clone the linoleate isomerase gene and to develop new 
production strains using recombinant technology. 
CLA (18:2), an octadecadienoic acid with two conjugated double bonds, has a variety of 
positional and geometric isomers. Numerous publications have demonstrated various biological 
and physiological benefits of CLA in animal and human health, such as inhibiting the initiation 
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of carcinogenesis and tumorigenesis, reducing atherosclerosis, improving hyperinsulinemia, 
altering the low density lipoprotein/high density lipoprotein cholesterol ratio, and reducing body 
fat, while increasing muscle mass (Pariza et al., 2001; Pariza, 2004). Although CLA is present in 
virtually all foods, especially dairy products and other foods derived from ruminant animals, this 
important nutrient may not be available in sufficient quantities in the human diet (Pariza, 2004). 
CLA is currently available as a dietary supplement, and it is produced by alkaline isomerization 
of linoleic acid (LA, c9,c12 octadecadienoic acid, 18:2) or vegetable oils rich in LA esters. 
Chemical isomerization results in predominantly c9,t11 and t10,c12 isomers (40–45% each) with 
a variety of other isomers (Reaney et al., 1999; Sehat et al., 1998). Recent studies have 
demonstrated separate and/or synergistic actions of the two biologically active isomers, c9,t11 
and t10, c12 CLA (Pariza, 2004). Therefore, single CLA isomers or isomers formulated at 
specific ratios represent the preferred compositional form.  
Processes to prepare single isomers from chemically synthesized mixtures are not 
practical on a large scale because of high cost of purification and difficulties in achieving high 
purity (Berdeaux et al., 1998; Chen et al., 1999; Hass et al., 1999).  LA isomerases catalyze the 
conversion of LA into single CLA isomers, c9,t11 or t10,c12 CLA, depending on the specific 
enzyme (Fig. 2.7). Tove’s group described an LA C12 isomerase that catalyzed the conversion of 
LA into c9,t11 CLA, an intermediate step in the biohydrogenation of LA to stearic acid in 
anaerobic rumen bacterium Butyrivibrio fibrisolvens (Kepler and Tove, 1967; Kepler et al., 1966, 
1971). The LA C12 isomerase has since been detected in a variety of bacteria (Coakley et al., 
2003; Peng et al., 2007; Rosson et al., 2001; Verhulst et al., 1985). Biotransformation of LA 
using microbial cells and enzyme extracts has been explored for the production of c9,t11 CLA 
(Ando et al., 2004; Rainio et al., 2001). Propionibacterium acnes and Megasphaera elsdenii 
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were reported to contain a LA C9 isomerase converting LA to t10,c12 CLA (Kim et al., 2002; 
Verhulst et al., 1987).  
Since February 2008 B. breve LAI sequence (accession number AX647943) (Stanton et 
al., 2002) and P. acnes LAI sequence (accession number AX062088) (Deng et al., 2007) were 
available in GenBank, Bifidobacterium and P. acnes LAI were chosen to be cloned in this study. 
However, Bifidobacteium LAI had never been cloned for heterologous production while P. acnes 
LAI activity expressed in E. coli DL21 (DE3) was very low (Deng et al., 2007). In addition, at 
that time there were two finished genome sequences, B. longum NC004307 (accession number 
AE014295) (Schell et al., 2002) and B. adolescentis ATCC 15703 (accession number 
AP009256) in GenBank. By comparison between three Bifidobacterium sequences, the primer 
sets for Bifidobacterium LAI amplification were designed. Moreover, the products of 
Bifidobacterium and P. acnes LAI are different. While B. breve LAI converts linoleic acid to 
c9,t11 CLA (Stanton et al., 2002), P. acnes LAI produces t10,c12 CLA (Deng et al., 2007).  By 
using these systems, each single CLA isomer will be able to generate.  
The aim of this part of the dissertation was to clone linoleate isomerase gene from 
Bifidobacterium species and Propionibacterium acnes into E. coli BL21 (DE3) and Bacillus 
species, respectively. The pET system with E. coli BL21 (DE3) were selected for protein 
expression in this study since this system claimed that the target proteins were produced in more 
than 50% of total protein (Novagen, pET system manual, 11th Edition, 2006). Since protein 
expression in E. coli BL21 (DE3) formed inclusion bodies and Bacillus species were 
subsequently chosen as other expression hosts. However, the detection of this enzyme activity is 
laborious and the enzyme activity may be low. The prepropeptides from S. hyicus lipase, B. 
subtilis nprE, and B. megeterium nprM were experimentally evaluated for promoting 
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heterologous secretion by using hydrolase from T. fusca and E. coli alkaline phosphatase PhoA 
as models. The expression vectors in this study were based on pMM1525 (Stammen et al., 2010). 
The -35 region and the ribosome-binding site on these expression vectors were systematically 
optimized for protein production maximization (Stammen et al., 2010).  Prepropeptide from S. 
hyicus lipase enhanced E. coli alkaline phosphatase PhoA secretion in B. subtilis (Kouwen et al., 
2010) while B. subtilis nprE, and B. megeterium nprM are the major extracellular proteases in B. 
subtilis, and B. megeterium nprM, respectively. B. megaterium YYBm1 was chosen to be the 
host in this study since the major extracellular protease nprM and xylose metabolism xylA genes 
were deleted.  
METHIONINE IN THE POULTRY INDUSTRY 
Methionine is a nutritionally essential amino acid required in the diet of humans and 
livestock, including poultry. Chickens are unable to produce methionine and therefore must 
obtain it through their diets. Generally, methionine is one of the first limiting amino acids in 
poultry nutrition and typically in most diets this amino acid has to be added to the poultry feed 
(Gomes and Kumar, 2005). In the U.S., approximately 90% of poultry feed is composed of corn 
and soybean which both are insufficient to meet methionine requirements of the bird (Baker, 
2009). The organic poultry industry faces an even tougher challenge regarding methionine 
supplementation in organic poultry feed.  Currently, formulated organic poultry feed contains 
insufficient amounts of methionine when fed which results in reducing growth rates of broilers 
(Rodenberg et al., 2008) as well as lowered egg weight in laying hens (Elwinger et al., 2008).   
Methionine is an essential amino acid and must be supplemented in most diets for normal 
growth and function of the body. Methionine supplementation in poultry production is known to  
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Fig. 2.7. Enzymatic conversion of LA to c9,t11 CLA by LA C12 isomerase and to 
t10,c12 CLA by LA C9 isomerase (Deng et al., 2007).  
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enhance feed efficiency, increase protein synthesis, and improve immune systems (Bunchasak, 
2009).  Methionine supplementation also prevented broiler chicks from developing neurological 
symptoms when raw grass pea seeds (Lathyrus sativus) were used as protein and energy sources 
in the diet (Fikre et al., 2010).  In addition, methionine in diets demonstrated an improved 
oxidative stability, an increase in color stability, and a decrease in drip loss in chicken meat 
(Wang et al., 2009).  Sufficient methionine levels in the diet have been shown to be necessary for 
sustaining normal immunocompetence and achieving maximum egg production in laying hens in 
subtropical conditions (Poosuwan et al., 2010).  Bunchasak and Silapasorn (2005) reported that 
laying hens under tropical conditions fed a low-protein diet (14 % crude protein) supplemented 
with 0.44% methionine improved egg production and egg weight.  In the same study bird 
mortality was reduced and egg shell thickness was improved when these hens were supported 
with methionine in feed. Conversely, insufficient methionine in organic feed showed a higher 
incidence of breast blisters in broilers (Rodenburg et al., 2008) or cannibalism in Hyline hens 
(Elwinger et al., 2008). The reduction of methionine content also decreased in the percentage of 
large and extra large eggs in Brown laying hens (Safaa et al., 2008).  
 Currently, methionine is produced by chemical processes or hydrolyzing proteins (Kumar 
and Gomes, 2005). However, chemical synthesis is expensive and produces a mixture of D- and 
L-methionine. In addition, these processes require hazardous chemicals such as acrolein, methyl 
mercaotan, ammonia, and cyanide (Fong et al., 1981). However, methionine from protein 
hydrolysis must be separated from the complex mixture (Kumar and Gomes, 2005). 
Furthermore, synthetic methionine is currently allowed as an additive to organic poultry feed by 
the U.S. Department of Agriculture’s National Organic Program (NOP) however NOP is only 
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extending its use until October 1st 2012 (USDA, Agricultural Marketing Service, 
http://www.paorganic.org/wp-content/uploads/2011/10/USDA-Methionine.pdf). 
Methionine production by microorganisms  
 A number of microorganisms capable of producing amino acids have been isolated and 
the production of amino acids has become an important aspect of industrial microbiology. Amino 
acids such as L-lysine, L-glutamic acid, L-threonine, and L-isoleucine have been produced 
successfully by fermentation (Hermann, 2003). Numerous studies have attempted to isolate and 
mutate microorganisms for overproduction of methionine but commercial methionine production 
from microorganisms is not available due to the highly branched pathway with complicated 
metabolic control in methionine biosynthesis (Kumar and Gomes, 2005). 
 Even though microorganisms use different biosynthetic routes, the pathways of 
methionine biosynthesis in various microorganisms have many common features (Fig. 2.8).  
First, aspartate is converted to aspartyl phosphate by aspartate kinase (EC 2.7.2.4, reaction  1) 
and then oxidized by aspartaldehyde semialdehyde dehydrogenase (EC 1.2.1.11, reaction 2) to 
form aspartate semialdehyse. The latter is oxidized by homoserine dehydrogenase (EC 1.1.1.3, 
reaction 3). Aspartate semialdehyde is subsequently converted to lysine. In one route, 
homoserine is converted to dihydropicolinate by dihydropicolinate synthase (reaction 8 and 9) 
and subsequently threonine and isoleucine production. In another pathway, homoserine 
undergoes condensation with acetyl CoA to produce O-acetyl homoserine by homoserine acetyl 
transferase (EC 2.3.1.31, reaction 4). Some yeasts, fungi, and bacteria can directly synthesize 
homocysteine from O-acetylhomoserine via the direct sulfhydrylation pathway by utilizing 
sulfide (S2-) as the sulfur donor. Cystathionine is synthesized from O-acetyl homoserine and 
cysteine by cystathionine γ-synthase (EC 4.2.99.9, reaction 5). After hydrolysis of cystathionine 
 32 
to homocysteine, pyruvate, and ammonia by cystathionine b-lyase (EC 4.4.1.8, reaction 6), 
methionine is formed by the methylation of homocysteine by methionine synthase. Two forms of 
methionine synthases are involved in the final methylation reactions. Vitamin B12 (cobalamin)-
dependent methionine synthase (EC 2.1.1.13, metH) utilizes N5- methyl-tetrahydrofolate or its 
polyglutamyl derivative as the methyl group donor, while the cobalamin-independent form (EC 
2.1.1.14, metE), utilizes N5-methyl-tetrahydropteroyl-triglutamate. 
 All microorganisms possess mechanisms to regulate enzymes such that excess amino 
acids production is avoided. For example, in Corynebacterium glutamicum, the activity of 
enzyme homoserine O-transacetylase was not inhibited by L-methionine, S-adenosylmethionine 
or S-adenoylhomocysteine (Kase and Nakayama, 1974). However, the synthesis of the enzyme 
was strongly repressed by L-methionine. The methionine biosynthesis is also regulated at the 
transcriptional level. In E. coli, MetJ repressor interacting with S-adenosylmethionine binds at 
met box, an eight-base consensus sequence, and subsequently leads to repression of the met 
genes, except metH (Weissbach and Brot, 1991). In general, met genes have at least two to five 
contiguous met boxes located at operator sequences. However, the MetR activator in E. coli 
stimulates the expression of metE and metH, encoding methionine synthases.  
 Numerous studies have attempted to mutate microorganisms for methionine 
overproduction by using N-methyl-N′-nitro-N-nitrosoguanidine UV irradiation. Several studies 
have reported that methionine-analog resistance in mutants correlated to higher methionine 
production due to an alteration in the regulation of L-methionine biosynthesis (Adelberg, 1958; 
Brigidi et al., 1988; Chattopadhyay et al., 1991; Dunyak and Cook, 1985; Komatsu et al., 1974; 
Morzycka et al., 1976; Musilkova and Fencl, 1964; Tani et al., 1988; Yamada et al., 1982). 
Rowbury (1965) reported that resistance to norleucine, a methionine analog, in microorganisms 
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is associated with a failure of methionine to repress any of the methionine biosynthetic enzymes 
by feedback effect. Based on this concept, two methionine analogs (ethionine and norleucine) are 
typically used to screen for methionine overproduction in either mutants or wild type 
microorganisms from various natural sources.  
The major cause of inhibition appears to be that methionine analogs mimic the means by 
which methionine regulates its own production (Gomes and Kumar, 2005). Methionine analogs 
can effectively function as true feedback inhibitors without participating in other functions in the 
cells. These analogs may bind to the product site of the enzyme or may bind effectively to the 
repressor and consequently shutdown the pathway for the synthesis of methionine. Analogs 
inhibit growth by starving the cell for methionine. Therefore, methionine analogs act as pseudo-
feedback inhibitors or repressors, thereby inhibiting or repressing the synthesis of methionine. 
Only strains having resistance to analogs may overproduce methionine. These strains are able to 
resist the analogs either because of an alteration in the structure of the enzyme or an alteration in 
the enzyme formation system. Natural methionine analog resistant strains are insensitive to 
methionine accumulation and thereby will overproduce methionine. Using methionine analogs to 
screen the methionine overproducing microorganism could be an efficient and robust method for 
the identification of commercial strains since these strains lack methionine feedback inhibition.  
Methionine detection 
For methionine quantification in animal feed, chemical methods including high 
performance liquid chromatography (HPLC) are commonly used (Chalova et al., 2010). By 
using the chemical methods, feeds are treated with acid digestion and the proteins in samples are 
completely digested. However, liberation of methionine is different from protein digestion under 
physiological conditions. Feed-derived methionine, which is available to animals to assimilate, 
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can be more accurately estimated by animal or microbial assays which correspond more directly 
to the physiological needs of animals (Parson et al., 1997). Although considered the biological 
standard, animal assays are laborious, expensive, and time consuming (Chalova et al., 2007; 
Cork et al., 1997; Froelich et al., 2005). 
In contrast to animal assays, microbial assays appear to be easier and more affordable for 
routine analysis. This method is based on microorganisms response to feed nutrients by 
increasing the population number of organisms (Froelich and Ricke, 2005). In contrast to animal 
assays, microbiological assays require smaller quantities of nutrients and respond in less time. 
Rapid development and recent improvements in molecular techniques allow for constructing 
successful and accurate amino acid biosensors via more precise genetic targeting of specific 
genes in microbial cells (Chalova et al., 2010). Among all microorganisms, E. coli is one of the 
most highly investigated bacteria for the purposes of biosensor fabrication. It is easy to cultivate, 
with simple nutritive requirements and rapid growth (Ingraham et al., 1983). Based on E. coli 
auxotroph, threonine, tryptophan, lysine, and glutamine quantification have all been successful. 
(Erickson et al., 2000; Hitcheins et al., 1989; Tessaro et al., 2012). Since E. coli is an intestinal 
bacterium of most animals and humans, the assimilation of amino acids would be similar to 
animals (Chalova et al., 2009). After feed ingredients treated with enzymes, Erickson et al. 
(1999) demonstrated a correlation of 0.94 between lysine bioavailability determined by using an 
E. coli lysine auxotroph and previously published chick bioassay data. An E. coli biosensor 
developed by Chalova et al. (2007) proved to be as accurate as the corresponding chick bioassay 
for lysine bioavailable quantitation in diverse feed ingredients. 
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Fig. 2.8. Methionine biosynthetic pathway in Corynebacterium glutamicum (Kuma and Gomes, 
2005). (1) Aspartate kinase, (2) aspartaldehyde dehydrogenase, (3) homoserine dehydrogenase, 
(4) homoserine O-acetyltransferase, (5) cystathionine γ-synthase, (6) cystathionine g-lyase, (7) 
homoserine S-methyltransferase (vitamin B12 independent or metH-encoded, vitamin B12 
dependent), (8) homoserine kinase, (9) threonine synthase 
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E. coli methioine auxotrophs have been constructed (Hitchins et al., 1989). However, 
these strains were mutated by using chemical mutagens and isolated based on the methionine 
requirement (Adelberg et al., 1965). As a result, the mutation is not target specific and various 
non-methionine related genes can be affected. Revertants or compensatory mutations may occur 
to abolish the desired functionality (Wright et al., 1997). In the case of methionine, the 
auxotrophic requirements for this amino acid are not specific and can also be satisfied by a 
variety of compounds including methioninyl peptides, α-hydroxy methionine, N-
acetylmethionine, and the α-keto analog α-keto-λ-methiol butyrate (Mulligan et al., 1982). When 
a chemically generated E. coli methionine auxotroph (ATCC 23798) was used, Froelich et al. 
(2002) observed no differences based on substrate affinities of an E. coli methionine auxotroph 
to methionine and methionine hydroxy analog, respectively. Estimated maximum growth rate of 
the E. coli auxotroph when grown on both substrates was also found to be similar. To avoid 
problems as mentioned above, in this study partial metC deletion was constructed from wild-type 
E. coli K12. Without methionine supplement at 1µg/ml, this mutant should be unable to grow.  
Microbial sources for organic poultry industry 
Many studies have attempted to isolate methionine producing microorganisms from 
environments or by genetic modification by using N-methyl-N′-nitro-N-nitrosoguanidine. Several 
studies have reported that methionine-analog resistance in bacterial strains correlated to higher 
methionine production due to an alteration in the regulation of L-methionine biosynthesis 
(Adelberg, 1958; Chattopadhyay et al., 1991; Musilkova and Fencl, 1964;Yamada et al., 1982 
Tani et al., 1988). Although the mutation was successful in producing methionine overproducing 
microorganisms, any genetically-modified organisms are considered unacceptable for use in 
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organic food production (Electric Code of Federal Regulations: U.S. National Organic Program).  
Therefore, wild type strains with methionine-producing ability are necessary for the organic 
poultry industry. The aims of this part of the PhD dissertation were to isolate methionine-
producing microorganisms and to quantify of methionine production from these strains; 
therefore, two methionine analogs were used to screen methionine overproduction in wild-type 
yeasts.  
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CHAPTER THREE 
LINOLEIC ACID ISOMERASE EXPRESSION  
IN E. coli BL21 (DE3) AND Bacillus SPECIES 
 
ABSTRACT 
Linoleic acid isomerase (LAI) is the enzyme responsible for converting linoleic acid 
(c9,c12, 18:2) to c9,t11 or c9,c12 conjugated linoleic acids. Conjugated linoleic acids are 
believed to lower cancer risk and enhance immunity. In this study, Bifodobacterium LAI gene 
was cloned into E. coli BL21 (DE3) by using pET24a(+) as the expression vector while 
Propionibacterium acnes LAI gene fused with pSSBm97 derivatives was expressed in Bacillus 
species. Even though the protein expressed of Bifidobacterium LAI was found in E. coli, no 
activity was detectable. The enzyme was possibly in an inactive form or activity was below 
detection. By changing cysteine residues to alanine, P. acnes LAI activity was present in B. 
megaterium YYBm1 but activity was not improved. From prepropeptide B. subtilis amyE fused 
with P. acnes LAI at N-terminus, the results showed that the proteins were unstable. Also, by 
transferring plasmids carrying prepropeptide Staphylococcus hyicus lipase and prepropeptide B. 
subtilis amyE fused with P. acnes LAI into B. licheniformis NRRLB-14212, LAI was not found 
due to possible proteolytic degradation.  
 
KEY WORDS: Bacillus, Bifidobacterium, heterologous expression, linoleic acid isomerase, 
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INTRODUCTION 
Conjugated linoleic acid (CLA, 18:2) is an octadecadienoic acid with two conjugated 
double bonds. These compounds possess abilities to lower cancer risk, enhance immunity and 
reduce body fat (Pariza et al., 2001; Pariza, 2004). CLA is currently marketed as a dietary 
supplement and is produced by alkaline isomerization of linoleic acid (LA) or vegetable oils 
containing triglyceride esters of LA (Peng et al., 2007); however, chemical synthesis produces a 
mixture of CLA (Reaney et al., 1999; Sehat et al., 1998) and the processes required to separate 
the respective single isomer are expensive (Berdeaux et al., 1998; Chen et al., 1999; Hass et al., 
1999).  
In contrast to chemical processes, biological processes originating from microorganisms 
can provide production of a single isomer of CLA (Deng et al., 2007). The LA C12 isomerase 
has since been detected in a variety of bacteria (Coakley et al., 2003; Peng et al., 2007; Rosson et 
al., 2001; Verhulst et al., 1985). Biotransformation of LA using microbial cells and enzyme 
extracts has been explored for the production of c9,t11 CLA (Ando et al., 2004; Rainio et al., 
2001). Propionibacterium acnes was reported to contain a LA C9 isomerase converting LA to 
t10,c12 CLA (Deng et al., 2007).  
There is an interest in developing commercial processes for the production of single 
isomers of CLA by biotransformation of LA using microbial cells and enzymes (Kim et al., 
2000; Rainio et al., 2001; Ando et al., 2004). However, the evaluation of these strains suggested 
that growth and linoleic acid isomerase (LAI) production levels by these anaerobes are 
insufficient to support economic commercial production of single CLA isomers (Peng et al., 
2007). A better alternative is to clone the LAI gene and to generate new production strains using 
recombinant technology.The aim of this study was to clone the linoleate isomerase gene from 
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Bifidobacterium species and Propionibacterium acnes into E. coli BL21 (DE3) and Bacillus 
species.  
MATHERIALS AND METHODS 
DNA manipulation for the construction of plasmids. 
The bacterial strains used in this study were described in Table 3.1. Kanamycin sulfate 
and cysteine hydrochloride were purchased from Sigma (St. Louis, MO). All restriction 
endonucleases and PCR master mix and T4 DNA ligase were purchased from Promega 
(Madison, WI).  
General methods.   
All Bifidobacterium strains were grown anaerobically (anaerobic jars with a gas pack in 
MRS broth supplemented with 0.05% (w/v) L-cysteine (98% pure; Sigma) and incubated at 37oC 
overnight.  Genomic DNA was prepared from Bifidobacterium strains by using QIAamp DNA 
Stool Mini Kit. Oligonucleotide primers were synthesized by Integrated DNA Technologies 
(Coralville, IA).   
Cloning of LA gene into pET24a(+).  
Linoleic acid isomerase (LAI) gene from B. breve (accession number AX647943) and 
two finished genome sequences, B. longum NC004307 (accession number AE014295) and B. 
adolescentis ATCC15703 (accession number AP009256), were aligned by using T-coffee 
(Notredame et al., 2000).   Primers (Table 3.2) were designed according to the potential LA 
sequences. PCR conditions (30 cycles) were: initial denaturation 95 oC, 120 s; denaturation, 95 
oC, 30 s, annealing, 45 oC, 30 s, extension 72 oC, 120 s, final extension, 72 oC, 7 min. PCR 
conditions were identical to all primer sets, except the annealing temperature (40 oC) for primers 
Bifido1F and Bifido1RHis. The 1990-bp PCR products were confirmed by agarose gel 
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electrophoresis. Insertion of all PCR products via the corresponding XhoI and NdeI restriction 
sites in pET24a(+) led to plasmid pET2 to pETH5 (Table 3.3). The plasmids pET2 to pETH5 
were transformed to E. coli BL21 (DE3) by electroporation. Individual colonies from kanamycin 
agar plates were selected. 
For Propionibacterium acnes LAI, the new DNA sequence was designed by JCat 
software (http://www.jcat.de/) (Grote et al., 2005) and was synthesized by Integrated DNA 
Technologies, Coralville, IA. The P. acnes LAI was used as the template and primers LF to A5F 
were used to change from 5 cysteine positions to alanine (Table 3.4). The PCR products were 
flanked by SpeI-EagI restriction sites, was digested with these enzymes, and subsequently 
inserted into pLPPL after SpeI-EagI digestion, creating the plasmids pA1, pA2, pA3, pA4, pA5, 
pA6. 
For prepropeptide B. subtilis amyE fused with P. acnes LAI, PCR product was amplified 
by using primers amyEF and amyER (amyEF: 5’tat atg taca ATG TTT GCA AAA CGA TTC 
AAA ACC TC -3'; AmyER: 5’ tat aag atc tac tagt  CTC ATT CGA TTT GTT CGC CGT-3’). 
The PCR products were flanked by BsrGI-SpeI restriction sites, was digested with these 
enzymes, and subsequently was inserted into pLPPL, pA1, pA2, pA3, pA4, pA5, pA6 after 
BsrGI-SpeI digestion, creating the plasmids pE0, pE1, pE2, pE3, pE4, pE5, pE6. 
Protoplast B. megaterium YYBm1 cells were transformed with the appropriate 
expression plasmids using a polyethylene glycol-mediated procedure described by Christie et al. 
(2008) while plasmids were transferred into B. licheniformis NRRLB-14212 by electroporation 
as described in Xue et al. (1999).  
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Enzymatic activity measurements. 
For E. coli BL21 (DE3), 50 ml of LB broth containing kanamycin (50 µg/ml) was 
inoculated (1:100, v/v) with a freshly grown overnight culture of strains hosting an isomerase 
expression plasmid. After growning at 37 oC for 3 hours, cultures were induced with 1 mM 
isopropylthio-β-D-galactoside (IPTG) for 2 hours.  
E. coli cultures were harvested by centrifugation at 10,000 xg for 10 min at 4 oC. Cells 
were suspended in BugBuster (Novagen, Darmstadt, Germany). The subcellular localization of 
heterologous protein production was separated following the protocol described in pET system 
manual 11th edition (Novagen, Darmstadt, Germany) and the protein samples were analyzed by 
SDS-PAGE.   
All Bacillus plasmid strains were grown in baffled shake flasks at 30 oC in Luria-Bertani 
(LB) medium at 200 rpm. Recombinant expression of genes under transcriptional control of the 
xylose-inducible promoter was induced by the addition of 0.5% (w/v) xylose at OD578 of 0.4.  
The secreted proteins were separated from cells by centrifugation at 10,000 xg, 4oC for 10 min. 
After separation by SDS-PAGE, proteins were transferred to a nitrocellulose membrane and 
detected with 6X his tag antibody (Abcam, Cambridge, MA) and horseradish peroxidase–anti-
rabbit immunoglobulin G conjugates.  
Linoleaste isomerase activity was carried out as described by Peng et al. (2007). The 
preparation of fatty acid methyl esters (FAME) was described in Lewis et al. (2000) and FAME 
was detected by gas chromatography with tridecanoic acid as the internal standard.  
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RESULTS AND DISCUSSION 
LA expression in E. coli BL21 (DE3) as the host 
 Among expression systems, E. coli is considered to be the first choice since numerous 
vectors, readily available engineered strains, and minimal technical requirements are already in 
place. In addition, this system is rapid due to short doubling times for the generation 
(approximately 20 min per generation) (Brondyk, 2009). In this study, E. coli BL21 (DE3) was 
chosen as the host. In this system it was suggested that the target protein was synthesized to an 
equivalent of more than 50% of the total cell protein within a few hours after induction (pET 
system manual 11th edition, 2006). By using SDS-PAGE, the results showed that the expression 
of LAI in E. coli was tightly controlled by IPTG (Fig. 3.1).  The soluble cytoplasm proteins in E. 
coli carrying plasmids were collecting and detected by SDS-PAGE (Fig. 3.2 and 3.3). The results 
demonstrated that these proteins were unstable in the cytoplasm and some strains, particularly 
strain H3 and H5, did not produce soluble cytoplasm proteins.  The soluble and insoluble 
cytoplasm proteins were collected to identify the localization of proteins (Fig. 3.4). The results 
demonstrated that 6X His tag adversely affected the solubility of LAI, particularly LAI 
originating from B. longum ATCC15707 (clones 2 versus H2, Fig.3.4). Since expressed proteins 
were sequestered in inclusion bodies, the lower temperature incubation might enhance enzymatic 
folding. At 21.5 oC incubation, the results from SDS-PAGE did not show improved folding of 
the enzyme (Fig. 3.5). Deng et al. (2007) reported that the folding of P. acnes LAI expressed in 
E. coli was interfered by the C-terminal 6X His tag. The activities of LAI from these clones were 
undetectable due to possible improper folding of enzyme or very low activities. Deng et al. 
(2007) reported that P. acnes LAI expressed in E. coli BL21 (DE3) was only 1 nmol/min/ml. 
The primary method to minimize inclusion body formation and maximize the formation of 
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soluble, properly folded proteins in the cytoplasm is lowering the incubation temperature to 15 to 
30 oC during the expression period because the reduced temperature reduces the rate of 
transcription, translation, refolding and thus increase proper folding (Brondyk, 2009). In this 
study, the incubation temperature was reduced to 21.5 oC; however, this method did not enhance 
the enzymatic activity. In addition, protein accumulated in inclusion bodies in this study is one of 
the disadvantages of protein expression in E. coli (Terpe, 2006). 
 Because of the inclusion body formation problems associated with Gram-negative 
bacterium E. coli, Gram-positive bacteria appear to be more promising hosts for large-scale 
production of recombinant proteins. B. megaterium YYBm1 and B. licheniformis NRRLB-14212 
were chosen for the hosts. By deleting nprM, the major extracellular protease, and xylA genes, 
the gene for xylose metabolism in B. megaterium DSM319, B. megaterium YYBm1 is well 
suited for extracellular protein production (Stammen et al., 2010).  B. licheniformis was chosen 
due to its ability to secrete large quantities of extracellular enzymes (Schallmey et al., 2004). 
 B. megaterium YYBm1 carrying pLPPL showed that this host produced secreted P. acnes 
LAI; however, no activity was detectable. Based on P. acnes LAI amino acid sequence, there are 
5 cysteine residues (Fig. 3.6). All five cysteine residues were changed to alanine by using 
primers LF to A5F (Table 3.4) with P. acnes LAI as the template but no activity in B. 
megaterium YYBm1 carrying pA1 to pA6 was detectable. Liu and Escher (1999) reported that 
the bioluminescence activity of the secreted Renilla luciferase could be improved after selective 
removal of sulfhydryl groups by substitution of cysteine residues. Since wild type Renilla 
luciferase protein contains an odd number of cysteine residues in amino acid sequence, they 
proposed that a free cysteine residue and/or unfavorable disulfide bond in secreted Renilla 
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luciferase could affect its bioluminescence activity and alanine, an amino acid considered to be 
one of the most neutral, was used for this purpose.  
 Based on matrix-assisted laser desorption ionization–time of flight mass spectrometry 
(MALDI-TOF MS), the results showed that propeptide S. hyicus lipase still attached with P. 
acnes LAI and might impede enzymatic activity. In the next step, propeptide B. subtilis amplase 
(amyE) was chosen since this propeptide enhanced the secreted human interferon-α in B. subtilis 
as the host. In addition, the propeptide B. subtilis amyE is only 8 amino acid length, compared to 
207 amino acid length in propeptide S. hyicus lipase. The plasmids pE0 to pE6 were transferred 
into B. megaterium YYBm1. Based on Western blot detected with 6X his tag antibody, no 
secreted proteins were found in these strains. The results demonstrated that the protein fused 
with propeptide B. subtilis amyE was unstable in B. megaterium YYBm1 as the host (data not 
shown), compared to human interferon-α in B. subtilis. 
Since attempts with B. megaterium YYBm1 were unsuccessful, B. licheniformis 
NRRLB-14212 was examined as a possible expression host. The plasmids pLPPL and pE0 were 
transferred into B. licheniformis NRRLB-14212 by electroporation. The plasmid pE0 constructed 
in E. coli could not be successfully transferred into the expression strain B. licheniformis, 
indicating a lethal effect. This result agrees with Brockmeier et al. (2006) that 25 of 173 
prepeptides could not be transferred into B. subtilis TEB1030. The secreted protein in B. 
licheniformis NRRLB-14212 carrying pLPPL could not be detected by Western blot (data not 
shown). Possibly, B. licheniformis NRRLB-14212, a wild type strain, has extracellular proteases 
or propeptide S. hyicus lipase was unable to protect P. acnes LAI from proteolytic degradation.  
In conclusion, Bifidobacterium LAI expressed in E. coli BL21 (DE3) did not function 
due to insoluble formation in inclusion bodies. Amino acid modification of P. acnes LAI 
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expressed in B. megatreium YYBm1 did not improve the activity.  Also, propeptide of B. subtilis 
amyE and both propeptides could not protect P. acnes LAI from proteolytic degradation in B. 
megaterium YYBm1 and B. licheniformis NRRLB-14212 as the hosts, respectively.  
ACKNOWLEDGEMENTS 
This work was supported by an Arkansas Biosciences Institute Grant.  We would like to 
thank Simon Stammen, Rebekka Biedendieck, and Dieter Jahn of Institute of Microbiology, 
Technische Universitat Braunschweig for providing plasmids and B. megterium YYBm1. We 
appreciate Robert Preston Story Jr. at the Center for Food Safety in the Department of Food 
Science, the University of Arkansas for supporting Bidifobacterium longum ATCC15707, 
Bacillus subtilis, Bacillus licheniformis NRRL B-14212. 
REFERENCES 
Ando, A., J. Ogawa, S. Kishino, and S. Shimizu. 2004. Conjugated linoleic acid production from 
castor oil by Lactobacillus plantarum JCM 1551. Enzyme Microb. Technol. 35:40-45. 
Berdeaux, O., L. Voinot, E. Angioni, P. Juaneda, and J. L. Sebedio. 1998. A simple method of 
preparation of methyl trans-10,cis-12- and cis-9,trans-11-octadecadienoates from methyl 
linoleate. J. Am. Oil Chem. Soc. 75:1749-1755. 
Brockmeier, U., M. Caspers, R. Freudl, A. Jockwer, T. Noll, and T. Eggert. 2006. Systematic 
screening of all signal peptides from Bacillus subtilis: a powerful strategy in optimizing 
heterologous protein secretion in Gram-positive bacteria. J. Mol. Biol. 362:393-402. 
Brondyk, W. H. 2009. Selecting an appropriate method for expressing a recombinant protein. 
Methods Enzymol. 463:131-147. 
Chen, C.-A., W. Lu, and C. Sih. 1999. Synthesis of 9Z,11E-octadecadienoic and 10E,12Z-
octadecadienoic acids, the major components of conjugated linoleic acid. Lipids 34:879-884. 
Christie, G., M. Lazarevska, and C. R. Lowe. 2008. Functional consequences of amino acid 
substitutions to GerVB, a component of the Bacillus megaterium spore germinant receptor. J. 
Bacteriol. 190:2014-2022. 
Coakley, M., R. P. Ross, M. Nordgren, G. Fitzgerald, R. Devery, and C. Stanton. 2003. 
Conjugated linoleic acid biosynthesis by human-derived Bifidobacterium species. J. Appl. 
Microbiol. 94:138-145. 
 65 
Deng, M. D., A. D. Grund, K. J. Schneider, K. M. Langley, S. L. Wassink, S. S. Peng, and R. A. 
Rosson. 2007. Linoleic acid isomerase fromPropionibacterium acnes: purification, 
characterization, molecular cloning, and heterologous expression. Appl. Biochem. 
Biotechnol. 143:199-211. 
Grote, A., K. Hiller, M. Scheer, R. Münch , B. Nörtemann, D. C. Hempel, and D. Jahn. 2005. 
JCat: a novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic 
Acids Res. 33:W526-W531. 
Haas, M., J. Kramer, G. McNeill, K. Scott, T. Foglia, N. Sehat, J. Fritsche, M. Mossoba, and M. 
Yurawecz. 1999. Lipase-catalyzed fractionation of conjugated linoleic acid isomers. 
Lipids 34:979-987. 
Kim, Y. J., R. H. Liu, D. R. Bond, and J. B. Russell. 2000. Effect of linoleic acid concentration 
on conjugated linoleic acid production by Butyrivibrio fibrisolvens A38. Appl. Environ. 
Microbiol. 66:5226-5230. 
Lewis, T., P. D. Nichols, and T. A. McMeekin. 2000. Evaluation of extraction methods for 
recovery of fatty acids from lipid-producing microheterotrophs. J. Microbiol. Methods. 43:107-
116. 
Liu, J., and A. Escher. 1999. Improved assay sensitivity of an engineered secreted Renilla 
luciferase. Gene 237:153-159. 
Notredame, C., D. G. Higgins, and J. Heringa. 2000. T-Coffee: A novel method for fast and 
accurate multiple sequence alignment. J. Mol. Biol. 302:205-217. 
Pariza, M. W. 2004. Perspective on the safety and effectiveness of conjugated linoleic acid. Am. 
J. Clin. Nutr. 79:1132S-1136S. 
Pariza, M. W., Y. Park, and M. E. Cook. 2001. The biologically active isomers of conjugated 
linoleic acid. Prog. Lipid Res. 40:283-298. 
Peng, S. S., M.-D. Deng, A. D. Grund, and R. A. Rosson. 2007. Purification and characterization 
of a membrane-bound linoleic acid isomerase fromClostridium sporogenes. Enzyme Microb. 
Technol. 40:831-839. 
Rainio, A., M. Vahvaselkä, T. Suomalainen, and S. Laakso. 2001. Reduction of linoleic acid 
inhibition in production of conjugated linoleic acid byPropionibacterium 
freudenreichii ssp. shermanii. Can. J. Microbiol. 47:735-740. 
Reaney, M. J. T., L. Ya-Dong, and N. D. Westcott. 1999. Commercial production of conjugated 
linoleic acid. Adv. Conjugat. Linoleic Acid Res. 1:39-54. 
Rosson, R. A., M.-D. Deng, A. D. Grund, and S. S. Peng. 2001. Linoleate isomerase. patent PCT 
WO0100846-A. 
 66 
Schallmey, M., A. Singh, and O. P. Ward. 2004. Developments in the use of Bacillus species for 
industrial production. Can. J. Microbiol. 50:1 - 17. 
Sehat, N., M. P. Yurawecz, J. A. Roach, M. M. Mossoba, J. K. Kramer, and Y. Ku. 1998. Silver-
ion high-performance liquid chromatographic separation and identification of conjugated linoleic 
acid isomers. Lipids 33:217-221. 
Stammen, S., B. K. Müller, C. Korneli, R. Biedendieck, M. Gamer, E. Franco-Lara, and D. 
Jahn. 2010. High-yield intra- and extracellular protein production using Bacillus megaterium. 
Appl. Environ. Microbiol. 76:4037-4046. 
Terpe, K. 2006. Overview of bacterial expression systems for heterologous protein production: 
from molecular and biochemical fundamentals to commercial systems. Appl. Microbiol. 
Biotechnol. 72:211-222. 
Verhulst, A., G. Semjen, U. Meerts, G. Janssen, G. Parmentier, S. Asselberghs, H. Vanhespen, 
and H. Evssen. 1985. Biohydrogenation of linoleic acid by Clostridium sporogenes, Clostridium 
bifermentans, Clostridium sordellii and Bacteroides sp. FEMS Microbiol. Ecol. 31:255-259. 
Xue, G. P., J. S. Johnson, and B. P. Dalrymple. 1999. High osmolarity improves the electro-
transformation efficiency of the gram-positive bacteria Bacillus subtilis and Bacillus 
licheniformis. J. Microbiol. Methods. 34:183-191. 
 67 
Table 3.1. Bacterial strains used in this study 
Bacterial strain 
 
Description Source 
E. coli BL21 
(DE3) 
This strain lacks the lon and opmT proteases and contains a 
copy of RNA the T7 RNA polymerase gene under the 
control of the lacUV5 promoter. These modifications 
enable stable expression of proteins using T7 promoter 
driven constructs 
 
Novagen, 
Darmstadt, 
Germany 
Bifidobacterium 
sp. 
  
  
B. longum 
ATCC15700 
 
Wild type  Robert Preston 
Story, Jr.  
B. breve 
ATCC15700 
 
Wild type ATCC, 
Manassas, VA 
B. adolescentis 
ATCC15703 
 
Wild type ATCC, 
Manassas, VA 
B. infantis 
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Table 3.2. Oligonucleotides used in this study 
Primer name Sequence Application 
 
Bifido1F 5’-CAG ACA TAT GTA CTA CAG 
CGG CAA YTA T-3’ 
Forward primer containing an NdeI site 
for cloning LA from B. breve ATCC 
15700 
Bifido1R 5’-CTA TCT CGA GTC AGA 
TYA CRY GGT ATY CGC GTA-
3’ 
Reverse primer containing an XhoI site 
for cloning LA from B. breve ATCC 
15700 
Bifido R1His 5’- CTA TCT CGA GGA TYA 
CRY GGT ATY CGC GTA-3’ 
Reverse primer containing an XhoI site 
for cloning LA from B. breve ATCC 
15700 with a C-terminal His6-tag 
longumF1 5’-CAGA CAT ATG TAC TAC 
AGC AGC GGC AAT-3’ 
Forward primer containing an NdeI site 
for cloning LA from B.longum ATCC 
15707 or B. infantis ATCC 25962 
longumR1 5’-CTAT CTC GAG TCA GAT 
TAC GCG GTA TTC GCG-3’ 
Reverse primer containing an XhoI site 
for cloning LA from B.longum ATCC 
15707 or B. infantis ATCC 25962 
longumR1His 5’-CTAT CTC GAG GAT TAC 
GCG GTA TTC GCG-3’ 
Reverse primer containing an XhoI site 
for cloning LA from B.longum ATCC 
15707 or B. infantis ATCC 25962 with a 
C-terminal His6-tag 
adolesF1 5’-CAGA CAT ATG TAC TAT 
TCC AAC GGC AAT-3’ 
Forward primer containing an NdeI site 
for cloning LA from B. adolescentis 
ATCC 15703 
adolesR1 5’-CTAT CTC GAG TCA GAT 
CAC GCC GTA TTC CTT-3’ 
Reverse primer containing an XhoI site 
for cloning LA from B. adolescentis 
ATCC 15703 
adolesR1His 5’-CTAT CTC GAG GAT CAC 
GCC GTA TTC CTT-3’ 
Reverse primer containing an XhoI site 
for cloning LA from B. adolescentis 
ATCC 15703 with a C-terminal His6-tag 
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Table 3.3. Plasmids used in this study 
plasmid  Description  Source 
 
pCR® 4-TOPO® Cloning vector for PCR products, Ampr, Kanr Invitrogen 
pET24a(+) Expression vector with an N-terminal His6-tag, Kanr Novagen 
pET2 pET24a(+) with NdeI-XhoI LA gene from B.longum 
ATCC 15707 
This work 
pETH2 pET24a(+) with NdeI-XhoI LA gene with His6-tag 
from B.longum ATCC 15707 
This work 
pET3 pET24a(+) with NdeI-XhoI LA gene from B. breve 
ATCC 15700 
This work 
pETH3 pET24a(+) with NdeI-XhoI LA gene with His6-tag 
from B. breve ATCC 15700 
This work 
pET4 pET24a(+) with NdeI-XhoI LA gene from B. 
adolescentis ATCC 15703 
This work 
pETH4 pET24a(+) with NdeI-XhoI LA gene with His6-tag 
from B. adolescentis ATCC 15703 
This work 
pET5 pET24a(+) with NdeI-XhoI LA gene from B. infantis 
ATCC 25962 
This work 
pETH5 pET24a(+) with NdeI-XhoI LA gene with His6-tag 
from B. infantis ATCC 25962 
This work 
pLPPL P. acnes linoleate isomerase inserted into SpeI and 
EagI sites of pPPlip; PxylA-(-35+ rbs+)-prepeptidelipA-
propeptidelipA- LAI P. acnes 
This work 
pA1 pLPPL derivative, C46A This work 
pA2 pLPPL derivative, C154A This work 
pA3 pLPPL derivative, C286A This work 
pA4 pLPPL derivative, C344A This work 
pA5 pLPPL derivative, C412A This work 
pA6 pLPPL derivative, C46A, C154A, C286A, C344A, 
C412A 
This work 
pE0 Prepropeptide B. subtilis amyE inserted into BsrGI 
and SpeI sites of pLPPL; PxylA-(-35+ rbs+)-
prepeptideamyE-propeptideamyE-LAI P. acnes 
This work 
pE1 pE0 derivative, C46A This work 
pE2 p E0 derivative, C154A This work 
pE3 p E0 derivative, C286A This work 
pE4 pE0 derivative, C344A This work 
pE5 pE0 derivative, C412A This work 
pE6 pE0 derivative, C46A, C154A, C286A, C344A, 
C412A 
This work 
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Table 3.4. Oligonucleotides used for LAI engineering in this study 
Primer Sequence 5’ to 3’ 
LF tat aag atc t act agt  ATGTCTATTTCTAAAGATTCTCG 
LR tat aag atc t CGG CCG TTA GTG ATG GTG 
A1R GAG AGT GAG CTT TAC CAC CTA CGT GAT CTG TAC G 
A1F GGT GGT AAA GCT CAC TCT CCA AAC TAC CAC G 
A2R CAG CTT CAG CAC CGT TTA AAG CTA AGA ATT CAT CGA A 
A2F TTA AAC GGT GCT GAA GCT GCT CGT GAT TTA TG 
A3R TTA CTA AAG CAG CAT CTA CCA TGT ATT GTT GGT  
A3F GTA GAT GCT GCT TTA GTA AAA GAA TAC CCA ACA ATT TCT GG 
A4R TTT GAC GAG CTT CTT CTT GTG TTT TAT CAG CGT AAT C 
A4F AAG AAG AAG CTC GTC AAA TGG TAT TAG ATG ATA TGG AAA 
A5R AGT AGT GAG CTA CTT CAT CGA AGT TAC CGA AAG AC 
A5F ATG AAG TAG CTC ACT ACT CTA AAG ATT TAG TAA CAC GTT 
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Fig. 3.1 Total cell protein fraction isolated from E. coli clones containing LAI gene originated 
from Bifidobacterium strains. 2: LAI gene originated from B. longum ATCC1570;  3: LAI gene 
originated from B. breve ATCC15700; 4: LA gene originated from B. adolescentis ATCC15703; 
5: LAI gene originated from B. infantis ATCC25962; H: LAI gene fused with 6X His tag.  
Clone #                2          3      4        5      H2       H3    H4    H5    
IPTG                 -    +    -   +  -   +   -   +    -   +   -   +   -   +   -   +   
97.4 kDa 
66.2 
45.0 
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Fig. 3.2 Soluble cytoplasmic protein fraction isolated from E. coli clones containing LAI gene 
originated from Bifidobacterium strains. 2: LAI gene originated from B. longum ATCC1570;  3: 
LAI gene originated from B. breve ATCC15700; 4: LAI gene originated from B. adolescentis 
ATCC15703; 5: LAI gene originated from B. infantis ATCC25962. 
97.4 kDa 
 
66.2 
Clone #                                           2                           3                         4                          5 
          
Incubation time (h)              0    2    4    8  12    0   2    4   8  12    0     2    4    8  12  0    2   4    8  12 
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Fig. 3.3 Soluble cytoplasmic protein fraction isolated from E. coli clones containing LAI gene 
originated from Bifidobacterium strains. 2: LAI gene originated from B. longum ATCC1570;  3: 
LAI gene originated from B. breve ATCC15700; 4: LAI gene originated from B. adolescentis 
ATCC15703; 5: LAI gene originated from B. infantis ATCC25962; H: LAI gene fused with 6X 
His tag.  
Clone #                                   H2                    H3                      H4                      H5 
 
Incubation time (h)     0    2   4   8  12   0    2   4   8   12  0   2    4   8   12   0  2    4   8  12 
97.4 kDa 
66.2 
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Fig. 3.4. Soluble (S) and insoluble (I) cytoplasmic protein fraction from E. coli clones containing 
LAI gene originated from Bifidobacterium strains after adding IPTG 4 hours at 25 oC incubation. 
2: LAI gene originated from B. longum ATCC1570;  3: LAI gene originated from B. breve 
ATCC15700; 4: LAI gene originated from B. adolescentis ATCC15703; 5: LAI gene originated 
from B. infantis ATCC25962; H: LAI gene fused with 6X His tag.  
97.4 kDa 
 
66.2 
Clone #                     2            H2             3           H3           4          H4            5          H5 
Fraction                 S      I      S     I      S      I     S     I     S      I      S      I       S     I       S      I  
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Fig 3.5. Soluble (S) and insoluble (I) cytoplasmic protein fraction isolated from E. coli clones 
containing LAI gene originated from Bifidobacterium strains after adding IPTG 4 hours at 21.5 
oC incubation. 2: LAI gene originated from B. longum ATCC1570;  3: LAI gene originated from 
B. breve ATCC15700; 4: LAI gene originated from B. adolescentis ATCC15703; 5: LAI gene 
originated from B. infantis ATCC25962; H: LAI gene fused with 6X His tag.  
 
Clone #                          2            H2           3             H3          4               H4            5            H5 
Fraction                       S    I        S    I         S   I         S  I       S  I           S    I        S    I          S   I  
97.4 kDa 
 
66.2 
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M S I S K D S R I A I I G A G P A G L A A G M Y L E Q A G F H D Y T I L E R T D H V G 
G K C H S P N Y H G R R Y E M G A I M G V P S Y D T I Q E I M D R T G D K V D G P K 
L R R E F L H E D G E I Y V P E K D P V R G P Q V M A A V Q K L G Q L L A T K Y Q G 
Y D A N G H Y N K V H E D L M L P F D E F L A L N G C E A A R D L W I N P F T A F G 
Y G H F D N V P A A Y V L K Y L D F V T M M S F A K G D L W T W A D G T Q A M F E 
H L N A T L E H P A E R N V D I T R I T R E D G K V H I H T T D W D R E S D V L V L T 
V P L E K F L D Y S D A D D D E R E Y F S K I I H Q Q Y M V D A C L V K E Y P T I S G 
Y V P D N M R P E R L G H V M V Y Y H R W A D D P H Q I I T T Y L L R N H P D Y A D 
K T Q E E C R Q M V L D D M E T F G H P V E K I I E E Q T W Y Y F P H V S S E D Y K 
A G W Y E K V E G M Q G R R N T F Y A G E I M S F G N F D E V C H Y S K D L V T R F 
F V 
Fig. 3.6. P. acnes LAI amino acid sequence. The underlines show the positions of cysteine.  
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M F A K R F K T S L L P L F A G F L L L F Y L V L A G P A A A S A ↓ E T A N K S N E 
Fig. 3.7. prepropeptide B. subtilis amyE amino acid sequence. The arrow shows the cutting site 
by Type I signal peptidase between prepeptide (signal peptide) and propeptide.  
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CHAPTER FOUR 
CONTRIBUTION OF THE PRE- AND PRO-REGIONS OF Staphylococcus hyicus 
LIPASE, Bacillus subtilis NEUTRAL PROTEASE, AND Bacillus megaterium THE 
MAJOR EXTRACELLULAR PROTEASE TO SECRETION OF HETEROLOGOUS 
PROTEINS BY Bacillus megaterium AND Bacillus licheniformis 
 
ABSTRACT 
 The secretion of heterologous proteins by using Bacillus species is a well-established 
system. However, inefficient translocation across the plasma membrane of heterologous proteins 
is a major problem when Bacillus species are employed as the expression hosts. A recent study 
showed that prepropeptide Staphylococcus hyicus lipase enhanced the secretion of heterologous 
proteins in B. subtilis. In this study, prepropeptides of S. hyicus lipase, B. subtilis nprE, and B. 
megaterium nprM were investigated by using hydrolase from T. fusca (Tfh) and E. coli alkaline 
phosphatase PhoA as models. The results show that the secreted Tfh and PhoA activities were 
lower when the proteins fused with propeptides, compared to those without propeptides. Only 
propeptide S. hyicus lipase protected Propionibacterium acnes linoleic acid isomerase from 
proteolytic degradation and did not impede the translocation. However, no activity of isomerase 
was detectable. MALDI-TOF MS of linoleic acid isomerase showed that the propeptide was still 
attached with secreted protein. In addition, the results of the propeptide S. hyicus lipase fused 
with B. subtilis nprE demonstrated that enzymatic activities were interfered with by the attached 
propeptide S. hyicus lipase.  
KEY WORDS: Bacillus subtilis, Bacillus megaterium, Bacillus licheniformis, heterologous 
protein, prepropeptide, Staphylococcus hyicus 
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INTRODUCTION 
 Heterologous production in bacterial systems, particularly E. coli, provide an economical 
route for protein production due to their ability to grow rapidly and yield high cell concentrations 
on inexpensive substrates (Terpe, 2006).  However, inclusion body formation, incorrect protein 
folding, and inefficient bond formation might occur by intracellular production in E. coli 
(Schallmey et al., 2004). To avoid these problems, Bacillus species as the hosts are an alternative 
way to secrete heterologous proteins into surrounding medium (Pohl and Harwood, 2010).  
 By using Bacillus species as the hosts, inefficient translocation across the plasma 
membrane could be one of the bottlenecks in the secretion of heterologous proteins (Li et al., 
2004). A recent study showed that prepropeptide Staphylococcus hyicus lipase enhanced the 
secretion of heterologous proteins in B. subtilis (Kouwen et al., 2010). Compared to B. subtilis, 
B. megaterium strains have the advantage of highly stable, freely replicating plasmids (Vary et 
al., 1994). In addition, a recent study developed expression plasmids for maximizing 
heterologous protein production (Stammen et al., 2010).  
Here, we investigate the suitability of several prepeptides and prepropeptides for the 
heterologous production and secretion by B. megaterium YYBm1 and B. licheniformis NRRL B-
14212. Prepropeptides from S. hyicus lipase, B. subtilis nprE, and B. megeterium nprM were 
experimentally evaluated for promoting heterologous secretion by using hydrolase from T. fusca 
and E. coli alkaline phosphatase PhoA as models. The prepropeptide from S. hyicus lipase  was 
chosen because it  had been previously demonstrated to be successful for enhancing E. coli 
alkaline phosphatase PhoA secretion in B. subtilis (Kouwen et al., 2010) while B. subtilis nprE, 
and B. megeterium nprM are the major extracellular proteases in B. subtilis, and B. megeterium, 
respectively.  
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MATERIALS AND METHODS 
DNA manipulation for the construction of plasmids. 
 The synthetic oligonucleotides used in this work are listed in Table 4.S1 in the 
supplemental material. The plasmids constructed or employed are listed in Table 4.1. E. coli 10G 
(Lucigen, Middleton, WI) was used for all cloning purposes. B. megaterium YYBm1 (Stammen 
et al., 2010), strain inactivated xylA gene for xylose metabolism and the major extracellular 
protease gene nprM was deleted, and B. licheniformis NRRL B-14212 were used as protein 
production hosts. Antibiotics were used at the following concentrations: ampicillin, 100 µg/ml; 
and tetracycline 10 µg/ml. 
 The basic expression plasmid of this study was pSSBm97 (Stammen et al., 2010). The 
oligonucleotides lipF, lipR, and lipR2 were used as primers for the PCR to amplifiy pre- and 
prepropeptide S. hyicus lipA lipase by using oligonucleotide PL1 to Pu12 as the template. For 
pre- and prepropeptide B. subtilis nprE neutral protease amplification, the oligonucleotide nprEF, 
nprER, nprER2 were used as primers and B. subtilis genomic DNA was used as the template. 
The oligonucleotides nprMF, nprMR, nprMR2 were used as primers for the PCR to amplifiy pre- 
and prepropeptide B. megaterium  nprM gene by using B. megaterium DSM319 as the template. 
Insertion of all PCR products via the corresponding BsrGI and SpeI restriction sites led to pPL, 
pPPL, pPE, pPPE, pPM, and pPPM, respectively.  
PhoA gene was amplified from E. coli K12 by using primers PhoF and PhoR. PCR 
product was cloned into pCR®4-TOPO and later into pSSBm97, pPL, pPPL, pPE, pPPE, pPM, 
and pPPM after SpeI-EagI digestion, resulting in construction of pA97, pAPL, pAPPL, pAPE, 
pAPPE, pAPM, pAPPM, respectively.  
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For P. acnes linoleate isomerase, the new DNA sequence was designed by JCat software 
(http://www.jcat.de/) (Grote et al., 2005) and was synthesized by Integrated DNA Technologies, 
Coralville, IA. The linoleate isomerase fragment was flanked by SpeI-EagI restriction sites, was 
digested with these enzymes, and was subsequently inserted into pSSBm97, pPL, pPPL, pPE, 
pPPE, pPM, and pPPM after SpeI-EagI digestion, creating the plasmids pL97, pLPL, pLPPL, 
pLPE, pLPPE, pLPM, pLPPM, respectively. 
The oligonucleotides enprEF and enprER were used as nprE gene amplification by using 
B. subtilis genome as the template and PCR product was cloned into pCR®4-TOPO. Insertion of 
the nprE PCR products via the corresponding SpeI and EagI restriction sites in plasmids pPL and 
pPPL led to pEPL and pEPPL, respectively. Protoplast B. megaterium YYBm1 cells were 
transformed with the appropriate expression plasmids using a polyethylene glycol-mediated 
procedure described by Christie et al. (2008) while plasmids were transferred into B. 
licheniformis NRRLB-14212 by electroporation as described in Xue et al. (1999).  
Protein production in Bacillus megaterium and B. licheniformis. 
 All B. megaterium and B. licheniformis plasmid strains were grown in baffled shake 
flasks at 30 or 37 oC in Luria-Bertani (LB) medium, TM medium (Takara Bio manual), 2SY 
medium (Takara Bio manual), MPB medium (Chiang et al., 2010), or MSR medium (Chiang et 
al., 2010) at 200 rpm. Recombinant expression of genes under transcriptional control of the 
xylose-inducible promoter was induced by the addition of 0.5% (w/v) xylose at OD578 of 0.4.  
Localization of heterologous protein expression 
The subcellular localization of heterologous protein production was determined using the 
protocol described in Kouwen et al. (2010). After separation by SDS-PAGE, proteins were 
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transferred to a nitrocellulose membrane and detected with 6X his tag antibody (Abcam, 
Cambridge, MA) and horseradish peroxidase–anti-rabbit immunoglobulin G conjugates.  
Proteomics  
Cells of B. megaterium were grown at 30 °C at 200 rpm. Cells were separated from the 
growth medium by centrifugation. The secreted proteins in the growth medium were collected 
for SDS-PAGE, gels were stained with Coomassie brilliant blue, and the respective protein 
bands were identified by matrix-assisted laser desorption ionization–time of flight mass 
spectrometry (MALDI-TOF MS). 
Enzymatic activity measurements. 
The hydrolase activity of the enzyme Tfh was measured as described by Stammen et al. 
(2010). The enzymatic release of p-nitrophenol was photometrically detected at 410 nm. One 
enzyme unit was defined as the amount that caused the release of 1 µmol p-nitophenol per 
minute under the given assay condition. The enzymatic activity was calculated using a molar 
absorption coefficient of 15,000 M-1 cm-1. 
Alkaline phosphatase (PhoA) activity was carried out as described by Darmon et al. 
(2006). PhoA activities, expressed in U/ml/unit of optical density at OD600, were determined by 
measuring changes in OD405 nm as a function of the time of incubation (in minutes) and the 
OD600. To do this, the following formula was used: [2/3 x (OD405 x 352)]/(t x OD600), where t 
is the time of incubation. Cells were separated from the growth medium by centrifugation. 
Protease activity was measured as described in Mansfeld and Ulbrich-Hofmann (2007). 
One unit of proteolytic acitivity was defined as the amount of enzyme yielding an increase of 
0.001 in the absence at 275 nm per min at 30 oC under standard reaction condition. All 
experiments were repeated at least three times. Linoleaste isomerase activity was carried out as 
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described by Peng et al. (2007). The preparation of fatty acid methyl esters (FAME) was 
described in Lewis et al. (2000) and FAME was detected by GC with tridecanoic acid as the 
internal standard.  
Statistical analyses 
Where standard deviations are presented in the respective figures, these values represent 
the average of at least triplicate measurements. The statistical tests for treatment effects were 
performed using an analysis of variance (ANOVA) procedure of Statistixs 9.1 Analytical 
Software (SAS Institute, Cary, NC). Means were further separated using least-significant 
difference multiple comparisons. 
RESULTS  
Fusion of Tfh and PhoA with prepropeptides from S. hyicus lipase, B. subtilis nprE, and B. 
megaterium nprM 
Kouwen et al. (2010) demonstrated that the prepropeptide of S. hyicus lipase enhanced 
the secretion of PhoA in B. subtilis. The prepropeptides of B. subtilis nprE and B. megaterium 
nprM were chosen because both are major extracellular proteases in these organisms. In this 
study, all plasmids originated from pSSBm97 (Stammen et al., 2010). Plasmid pSSBm97 
contains an optimal the -35 region and the ribosome-binding site, enhancing heterologous 
production in B. megaterium YYBm1 (Stammen et al., 2010).  
The secreted amounts of active Tfh were assessed by measuring hydrolase activity in 
growth medium of cells containing the seven different prepropeptides (Fig. 4.1). Analysis of the 
medium fractions showed that the highest Tfh activity was detected in growth medium of cells 
carrying yocH as the prepeptide (pSSBm97), while the levels of Tfh activity were lower (P < 
0.05) in the medium of cells expressing other prepropeptides. Surprisingly, the levels of active 
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Tfh in the medium of cells expressing prepropeptide S. hyicus lipase and B. subtilis nprE were 
significantly lower than those cells containing only prepeptides.  
For secreted PhoA levels in B. megaterium, seven prepropeptides were fused with PhoA 
at the N-terminus. Analysis of the medium fractions showed that the levels of PhoA of cells 
expressing prepropeptides were lower than cells of expressing only their pair prepeptides (Fig. 
4.2); however, the levels between their pair prepeptides and prepropeptides were not 
significantly different. In this case, the lowest level of active PhoA in the medium fraction was 
cells carrying yocH as prepeptide (pA97).  
Linoleate isomerase production in B. megaterium and B. licheniformis 
 Linoleate isomerase in P. acnes is the enzyme that isomerizes  the double bond at the C9 
position in linoleic acid (c9,c12, 18:2) to form t10,c12 conjugated linoleic acid  (Deng et al., 
2007). The conjugated linoleic acids have been demonstrated to exhibit anti-cancer, anti-diabetic, 
and immune-enhancing properties (Pariza, 2004). This gene was expressed in E. coli BL21 
(DE3) as the host; unfortunately, the recombinant enzyme formed an inclusion body (Deng et al., 
2007). Secreted protein production might solve the formation of insoluble protein inclusion 
bodies from intracellular accumulations (Schallmey et al., 2004).  
 The major goal of this investigation was the extracellular linoleate isomerase production 
by B. megaterium and B. licheniformis. By using the 6X His tag antibody detection, only cells 
expressing prepropeptide S. hyicus lipase produced linoleate isomerase (Fig. 4.3). To analyze 
whether the lack of P. acnes linoleate isomerase production after fusions with prepropeptides, 
except with prepropeptide S. hyicus lipase, was due to a failure in secretion or to instability of the 
protein, the total cell samples were probed with the 6X his tag-specific antibody (Fig. 4.4). Only 
a distinct band from B. megaterium carrying pLPPL was observed, suggesting that the protein 
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was reasonably stable. No corresponding protein occurred in the other cells with prepropeptides, 
indicating that these proteins were less stable.  
 To observe the efficient translocation across protoplast membrane, the cells expressing 
prepropeptide S. hyicus lipase fused with linoleate isomerase were divided into medium, total 
cell, cell wall, protoplast, protoplast incubated with trypsin, and protoplast incubated with trypsin 
and Triton X-100 fractions. The proteins from medium, total cell, cell wall, and protoplast 
fractions were all the same size (Fig. 4.5), representing no processing of translocated linoleate 
isomerase after crossing the membrane. The protein in proplasts was degraded when adding 
trypsin, suggesting that the protein was effectively translocated across the protoplast membrane.  
 In order to maximize linoleate isomerase production, the cells carrying pLPPL were 
cultured under various conditions. The results from the 6X His tag antibody detection showed 
that MPB enhanced more linoleate isomerase production than other media (Fig. 4.6). In addition, 
a different set of forms of linoleate isomerase larger than the major band could represent an 
aggregated form of linoleate isomerase or linoleate isomerase bound to other proteins. In 
addition to the major protein from cells culturing in MSR medium, minor bands of lower mass 
reacted with the antibody, suggesting that they represented shortened species of the fusion 
protein. By culturing at 37 oC in MPB medium, the supernatant of cells expressing prepropeptide 
S. hyicus lipase exhibited smear bands, indicating proteolytic degradation, compared to supernant 
from cells cultured at 30 oC (Fig. 4.7). The 6X His tag antibody detection showed that the 
linoleate isomerase was initially detectable 4 hours and increased production up to 8 hours after 
xylose addition (Fig. 4.8). After 8 hours induction, the amounts of protein were reduced due to 
possible proteolytic degradation.  
 86 
 To observe linoleate isomerase activity, B. megaterium YYBm1 carrying pLPPL was 
cultured in MPB medium and the supernatant was collected at 8 hours after xylose addition. The 
supernatant was incubated with linoleate as described in Peng et al. (2007). FAME was prepared 
as described in Lewis et al. (2000); however, no activity was detected. 
 Since no activity was found when B. megaterium YYBm1 was used as the host, B. 
licheniformis and B. subtilis were chosen due to their abilities to secrete large quantities of 
extracellular enzymes (Schallmey et al., 2004). The plasmids L97 to pLPPL were transferred into 
B. licheniformis NRRL B-14212 by electroporation; however, plasmid pLPPE transformation 
was unsuccessful. Unfortunately, no plasmid transformation was successful in B. subtilis. B. 
licheniformis carrying these plasmids were cultured in LB medium at 37 oC and the supernatant 
was collected at 6 hours after xylose supplement; unfortunately, no protein was detected by using 
the 6X His tag antibody.  
Protease production in B. megaterium 
 Since prepropeptide S. hyicus lipase fusion impeded Tfh (Fig. 4.1) and PhoA activities 
(Fig. 4.2) but supported secreted linoleate isomerase production (Fig. 4.3), B. subtilis nprE gene 
was chosen for the further evaluation of this propeptide on secreted protein in B. megaterium. By 
measuring active protease in the medium fractions collected from B. megaterium expressing pre- 
and prepropeptide S. hyicus fused with nprE gene, the results showed that the secreted NprE did 
not require propeptide for translocation; however, its activity was inhibited by the propeptide 
fusion (Fig. 4.9). In addition, the results from the secreted NprE proteins detected by the 6X His 
tag antibody showed that cells expressing prepropeptide S. hyicus lipase produced a larger form 
than proteins from cells expressing prepeptide (data not shown).  
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Peptide analysis by MALDI-TOF MS 
 B. megaterium carrying pLPPL was cultured in MPB medium at 30 oC and the sample 
was collected at 8 hours after xylose induction. The major protein band in SDS-PAGE was 
excised and digested with trypsin. Subsequently, the peptide sample was analyzed by MALDI-
TOF MS. From the peptide mass fingerprint obtained from the MALDI-TOF MS (Fig. 4.10), the 
intense peaks were selected and subjected to MS/MS ion search. The MS/MS data were analyzed 
both by running MASCOT (http://www.matrixscience.com) as well as manual analysis in order 
to identify the protein. MS/MS spectra were searched with GPS software using 95% confidence 
interval threshold (P < 0.05), with which a minimum Mascot score of > 61 was considered 
imperative for further analysis. From the peptide analysis, the results demonstrated that 
propeptide S. hyicus lipase was still attached with the linoleate isomerase (Fig. 4.11).  
DISCUSSION 
In this study, two enzymes, Thf and PhoA, were chosen to be model proteins to study the 
influence of prepropeptides on export efficiency in B. megaterium. Tfh has been shown to be 
successful for generating secreted protein in B. megaterium YYBm1 up to 7,200 U per liter 
(Stammen et al., 2010). PhoA from E. coli was the other model protein because it contains two 
disulfide bonds which is one of the limitations for heterologous production in Bacillus species 
(Kouwen and van Dijl, 2009).  
From Tfh and PhoA activity measurement, the results showed that prepeptide yocH and 
prepeptide nprE were the best choices for secreted protein production. Currently, every secreted 
heterologous proteins requires prepeptide optimization (Brockmeier et al., 2006). In some cases, 
the efficiency of heterologous protein secretion with each prepeptide depends on each strain. By 
comparing between two strains of B. lichniformis, most prepeptides, except SacC, showed 
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related secretion efficiency (Degering et al., 2010).  Surprisingly, the Tfh and PhoA activities in 
medium of three-pair propeptide addition were lower compared to the cells proteins expressing 
without propeptides.  
Linoleate isomerase is the enzyme for modifying linoleic acid to conjugated linoleic acids 
which are anti-carcinogenic compounds (Deng et al., 2007). This enzyme formed inclusion 
bodies when expressing in E. coli BL21 (DE3) (Deng et al., 2007). The goal of this investigation 
was to secrete active linoleate isomerase in B. megaterium. Sturmfels et al. (2001) demonstrated 
propeptide lipase was necessary for human growth hormone translocation process at S. carnosus 
membrane and Kouwen et al. (2010) demonstrated that propeptide S. hyicus lipase significantly 
enhanced the secretion of PhoA by B. subtilis.  
In general, heterologous proteins are vulnerable to wall-associated proteases during the 
slow protein-folding process (Braun et al., 1999). The results in this study showed that the 
propeptide protected linolated isomerase from proteolytic degradation in B. megaterium cells. 
Demleitner and Gotz (1994) reported that the second half of this propeptide maintained lipase 
stability in S. carnosus cells and proposed that the heterologous protein without propeptide was 
degraded in intracellular or at the membrane site during translocation. Kouwen and van Dijl 
(2009) proposed that propeptide might function like chaperone to form protein correctly, and 
therefore, enzyme was not degraded inside the cells. Meens et al. (1997) concluded that the 
propeptide facilitates the release of unfolded proteins from the translocase and/or passage 
through the cell wall, protecting them form proteases at the membrane-cell wall interface.  
In this study, MPB medium appeared to maximize linoleate isomerase production, similar 
to Rluc production in B. subtilis (Kakeshita et al., 2011). When the host cells Bacillus subtilis 
grew on the MSR medium, production of recombinant protein Rluc was unsuccessful. A 
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detectable amount of Rluc was found when B. subtilis growing on MPB medium. It should be 
noted that the composition of the MSR and MPB media are similar except that glucose in the 
former is substituted with casamino acid in the latter. It suggests that the nitrogen source instead 
of carbon is flavorable for the production of Rluc by B. subtilis.   
The results of linoleate isomerase activity, NprE activity, NprE detection by the 6X His 
tag antibody, peptide analysis of by MALDI-TOF MS showed that propeptide was still attached 
with the enzymes and might inhibit enzyme activities. In S. hyicus, the prepeptide is cleaved after 
the propeptide-enzyme complex is released into the culture medium (Sarvas etal., 2004). The 
propeptide is subsequently removed by a metalloprotease, and full enzymatic activity is achieved 
(Sarvas et al., 2004; Yabuta et al., 2001). Ayora et al. (1994) demonstrated that ShpII, a neutral 
metalloprotease in S. hyicus, is necessary for the propeptide removal. The propeptide-PhoA 
complex produced by B. subtilis 168 (trpC2) showed that the propeptide was removed when the 
complex was released into the medium (Kouwen et al., 2010); however, the propeptide-OmpA 
complex produced by B. subtilis DB104 (his, nprR2, nprE18, ∆aprA3) was unprocessed after 
releasing into the medium (Meens et al., 1997). NprE is an extracellular major metalloprotease in 
B. subtilis (He et al., 1991) and might remove the propeptide from the propeptide-PhoA 
complex. From B. megaterium DSM319 genome analysis, an extracellular metalloprotease InhA 
was reported (Eppinger et al., 2011); however, the propeptide removal was not found in this 
study.  
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Table 4.1.  Plasmids used in this study 
Plasmid  Description Source 
pSSBm97 PxylA-(-35+ rbs+)-prepeptideyocH-tfh Stammen et al., 
(2010) 
pPlip prepeptide of S. hyicus lipA lipase inserted into BsrGI and 
SpeI sites of pSSBm97; PxylA-(-35+ rbs+)-prepeptidelipA-tfh 
This study 
pPPlip prepropeptide of S. hyicus lipA lipase inserted into BsrGI and 
SpeI sites of pSSBm97; PxylA-(-35+ rbs+)-prepeptidelipA-
propeptidelipA-tfh 
This study 
pPnprE prepeptide of B. subtilis nprE neutral protease inserted into 
BsrGI and SpeI sites of pSSBm97; PxylA-(-35+ rbs+)-
prepeptidenprE-tfh 
This study 
pPPnprE prepropeptide of B. subtilis nprE neutral protease inserted 
into BsrGI and SpeI sites of pSSBm97; PxylA-(-35+ rbs+)-
prepeptidenprE-propeptidenprE-tfh 
This study 
pPnprM prepeptide of B. megaterium  nprM neutral protease inserted 
into BsrGI and SpeI sites of pSSBm97; PxylA-(-35+ rbs+)-
prepeptidenprM-tfh 
This study 
pPPnprM prepropeptide of B. megaterium  nprM neutral protease 
inserted into BsrGI and SpeI sites of pSSBm97; PxylA-(-35+ 
rbs+)-prepeptidenprE-propeptidenprM-tfh 
This study 
pCR®4-
TOPO 
Plasmid used for cloning PCR product Invitrogen 
 
pA97 E. coli phoA alkaline phosphatase inserted into SpeI and EagI 
sites of pSSBm97; 
PxylA-(-35+ rbs+)-prepeptideyocH-PhoA 
This study 
pAPL E. coli phoA alkaline phosphatase inserted into SpeI and EagI 
sites of pPlip; 
PxylA-(-35+ rbs+)-prepeptidelipA-PhoA 
This study 
pAPPL E. coli phoA alkaline phosphatase inserted into SpeI and EagI 
sites of pPPlip; 
PxylA-(-35+ rbs+)-prepeptidelipA-propeptidelipA-PhoA 
This study 
pAPE E. coli phoA alkaline phosphatase inserted into SpeI and EagI 
sites of pPnprE;  
PxylA-(-35+ rbs+)-prepeptidenprE-PhoA 
This study 
pAPPE E. coli phoA alkaline phosphatase inserted into SpeI and EagI 
sites of pPPnprE;  
PxylA-(-35+ rbs+)-prepeptidenprE-propeptidenprE-PhoA 
This study 
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Table 4.1.  (continued) 
Plasmid  Description Source 
pAPM E. coli phoA alkaline phosphatase inserted into SpeI and EagI 
sites of pPnprM;  
PxylA-(-35+ rbs+)-prepeptidenprM-PhoA 
This study 
pAPPM E. coli phoA alkaline phosphatase inserted into SpeI and EagI 
sites of pPPnprM;  
PxylA-(-35+ rbs+)-prepeptidenprE-propeptidenprM-PhoA 
This study 
pL97 P. acnes linoleate isomerase inserted into SpeI and EagI sites 
of pSSBm97; 
PxylA-(-35+ rbs+)-prepeptideyocH-pal 
This study 
pLPL P. acnes linoleate isomerase inserted into SpeI and EagI sites 
of pPlip; 
PxylA-(-35+ rbs+)-prepeptidelipA-pal 
This study 
pLPPL P. acnes linoleate isomerase inserted into SpeI and EagI sites 
of pPPlip; 
PxylA-(-35+ rbs+)-prepeptidelipA-propeptidelipA-pal 
This study 
pLPE P. acnes linoleate isomerase inserted into SpeI and EagI sites 
of pPnprE;  
PxylA-(-35+ rbs+)-prepeptidenprE-pal 
This study 
pLPPE P. acnes linoleate isomerase inserted into SpeI and EagI sites 
of pPPnprE;  
PxylA-(-35+ rbs+)-prepeptidenprE-propeptidenprE-pal 
This study 
pLPM P. acnes linoleate isomerase inserted into SpeI and EagI sites 
of pPnprM;  
PxylA-(-35+ rbs+)-prepeptidenprM-pal 
This study 
pLPPM P. acnes linoleate isomerase inserted into SpeI and EagI sites 
of pPPnprM;  
PxylA-(-35+ rbs+)-prepeptidenprE-propeptidenprM-pal 
This study 
pEPL B. subtilis nprE  inserted into SpeI and EagI sites of pPlip; 
PxylA-(-35+ rbs+)-prepeptidelipA-nprE 
This study 
pEPPL B. subtilis nprE inserted into SpeI and EagI sites of pPPlip; 
PxylA-(-35+ rbs+)-prepeptidelipA-propeptidelipA-nprE 
This study 
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Fig. 4.1. Secretion of active Tfh. Strain YYBm1 without plasmid was used as a negative control. 
Samples were taken 6 hours after the xylose supplement. The activities are expressed in U/ml. 
a,b,c Means within the same sample measurements with unlike superscripts (P < 0.05). Error bars 
indicate standard deviations between enzyme activities detected for each construct.  
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Fig. 4.2. Secretion of active PhoA. Strain YYBm1 without plasmid was used as a negative 
control. Samples were taken 6 hours after the xylose supplement. The activities are expressed in 
U/ml. a,b Means within the same sample measurements with unlike superscripts (P < 0.05). Error 
bars indicate standard deviations between enzyme activities detected for each construct.  
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Fig. 4.3. Secretion of linoleate isomerase in B. megaterium.  Cells carrying plasmids were 
cultured in LB at 37 oC and were collected at 6 hours after xylose induction. Proteins from 3 ml 
of cell-free supernatants from B. megaterium cultures carrying plasmids were precipitated with 
trichloroacetic acid. Samples were used for SDS-PAGE and Western blotting. The 6X His tag 
antibody was used to detect the proteins.  
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Fig. 4.4. Total cell samples of linoleate isomerase in B. megaterium. Cells carrying plasmids 
were cultured in LB at 37 oC and were collected at 6 hours after xylose induction. Proteins from 
50 µl of cells were collected by centrifugation. Samples were used for SDS-PAGE and Western 
blotting. The 6X His tag antibody was used to detect the proteins.  
 
 
 
 
 
Y
Y
B
m
1 
 L9
7 
 LP
L 
 LP
PL
 
  LP
E 
 LP
PE
 
 LP
M
 
 LP
PM
 
 99 
 
 
 
 
 
 
 
 
 
Fig. 4.5. Secretion and subcellular localization of linoleate isomerase in B. megaterium.  
Cells carrying pLPPL were cultured in LB at 37 oC and were collected at 6 hours after xylose 
induction. The sample was divided into medium, total cells, cell walls, protoplasts. Protoplasts 
were incubated for 30 min in the presence of 1 mg/ml of trypsin with or without 1% Triton X-
100. Samples were used for SDS-PAGE and Western blotting, and 6X His tag antibody was used 
to detect the proteins.  
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Fig. 4.6. Secretion of linoleate isomerase in B. megaterium. Cells carrying pLPPL were cultured 
in LB, 2SY, TM, MPB, and MSR media at 37 oC and were collected at 6 hours after xylose 
induction. Proteins from 6 ml of cell-free supernatants from B. megaterium cultures carrying 
plasmids were precipitated with trichloroacetic acid. Samples were used for SDS-PAGE and 
Western blotting. The 6X His tag antibody was used to detect the proteins.  
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Fig. 4.7. Secretion of linoleate isomerase in B. megaterium. Cells carrying pLPPL were cultured 
in MPB medium at 30 and 37 oC and were collected at 6 hours after xylose induction. Proteins 
from 4.5 ml of cell-free supernatants from B. megaterium cultures carrying plasmids were 
precipitated with trichloroacetic acid. Samples were used for SDS-PAGE and Western blotting. 
The 6X His tag antibody was used to detect the proteins.  
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Fig. 4.8. Secretion of linoleate isomerase in B. megaterium. Cells carrying pLPPL were cultured 
in MPB medium at 30 oC and were collected at 0, 4, 6, 8, 10, 15, and 20 hours after xylose 
induction. Proteins from 4.5 ml of cell-free supernatants from B. megaterium cultures carrying 
plasmids were precipitated with trichloroacetic acid. Samples were used for SDS-PAGE and 
Western blotting. The 6X His tag antibody was used to detect the proteins.  
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Fig. 4.9. Secretion of active protease. Strain YYBm1 without plasmid was used as a negative 
control. Samples were taken 6 hours after the xylose supplement. The activities are expressed in 
U/ml. a,b Means within the same sample measurements with unlike superscripts (P < 0.05). Error 
bars indicate standard deviations between enzyme activities detected for each construct.  
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Fig. 4.10. A typical peptide mass fingerprint of trypsin digested proteins from B. megaterium 
carrying pLPPL.  
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Fig.4.11. Amino acid sequences of prepropeptide S. hyicus lipase and P. cenes linoleate 
isomerase in plasmid LPPL. The underlines show the amino acid sequences obtained from 
MALDI-TOF MS results.  
Prepeptide sequence 
M K E T K H Q H T F S I R K S A Y G A A S V M V A S C I F V I G G G V A E A 
 
Propeptide sequence 
N D S T T Q T T T P L E V A Q T S Q Q E T H T H Q T P V T S L H T A T P E H V D D S 
K E A T P L P E K A E S P K T E V T V Q P S S H T Q E V P A L H K K T Q Q Q P A Y K 
D K T V P E S T I A S K S V E S N K A T E N E M S P V E H H A S N V E K R E D R L E 
T N E T T P P S V D R E F S H K I I N N T H V N P K T D G Q T N V N V D T K T I D T V 
S P K D D R I D T A Q P K Q V D V P K E N T T A Q N K F T S Q A S D K K P T  
 
Linoleate isomerase sequence 
M S I S K D S R I A I I G A G P A G L A A G M Y L E Q A G F H D Y T I L E R T D H V G 
G K C H S P N Y H G R R Y E M G A I M G V P S Y D T I Q E I M D R T G D K V D G P 
K L R R E F L H E D G E I Y V P E K D P V R G P Q V M A A V Q K L G Q L L A T K Y 
Q G Y D A N G H Y N K V H E D L M L P F D E F L A L N G C E A A R D L W I N P F T 
A F G Y G H F D N V P A A Y V L K Y L D F V T M M S F A K G D L W T W A D G T Q 
A M F E H L N A T L E H P A E R N V D I T R I T R E D G K V H I H T T D W D R E S D 
V L V L T V P L E K F L D Y S D A D D D E R E Y F S K I I H Q Q Y M V D A C L V K E 
Y P T I S G Y V P D N M R P E R L G H V M V Y Y H R W A D D P H Q I I T T Y L L R N 
H P D Y A D K T Q E E C R Q M V L D D M E T F G H P V E K I I E E Q T W Y Y F P H 
V S S E D Y K A G W Y E K V E G M Q G R R N T F Y A G E I M S F G N F D E V C H Y 
S K D L V T R F F V 
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SUPPLEMENTARY MATERIAL  
Table S1. Oligonucleotides used in this study 
Primer Sequence 5’ to 3’ 
PL1 TTC ACG TTT TTC CAC ATT TGA AGC ATG ATG TTC AAC AGG TGA CAT 
CTC ATT TTC TGT TGC 
PL2 TTT ATT TGA TTC AAC CGA CTT TGA TGC TAT CGT TGA CTC TGG TAC 
CGT TTT ATC CTT ATA 
PL3 CGC CGG TTG TTG CTG TGT TTT TTT ATG TAA CGC AGG TAC TTC CTG 
TGT ATG CGA TGA AGG 
PL4 TTG AAC TGT CAC TTC GGT TTT TGG TGA CTC TGC TTT TTC AGG TAA 
AGG TGT TGC TTC TTT 
PL5 AGA GTC ATC AAC ATG TTC AGG TGT TGC AGT ATG TAA TGA TGT AAC 
AGG TGT TTG ATG TGT 
PL6 ATG TGT TTC TTG CTG CGA CGT TTG AGC GAC TTC TAG TGG TGT CGT 
TGT TTG TGT TGT CGA 
PL7 ATC ATT TGC CTC TGC CAC GCC CCC ACC GAT GAC AAA TAT ACA TGA 
TGC GAC CAT AAC CGA 
PL8 CGC GGC ACC ATA AGC CGA CTT ACG GAT AGA AAA TGT GTG 
PL9 TTG ATG TTT TGT TTC TTT CAT GAC CTT GTG TTC TCC TCC TCT 
PL10 TGT TGG TTT TTT GTC GCT CGC TTG TGA TGT AAA TTT ATT TTG TGC CGT 
TGT ATT TTC TTT 
PL11 AGG AAC GTC GAC TTG TTT CGG TTG CGC CGT ATC TAT TCT GTC ATC 
TTT CGG TGA AAC GGT 
PL12 GTC TAT CGT TTT CGT ATC AAC ATT AAC GTT TGT TTG TCC ATC CGT TTT 
TGG ATT TAC GTG 
PL13 CGT ATT ATT GAT GAT TTT ATG GCT AAA TTC ACG GTC CAC TGA TGG 
PL14 CGG TGT TGT CTC ATT AGT CTC CAA TCT ATC TTC ACG TTT TTC CAC 
PU1 AGA GGA GGA GAA CAC AAG GTC  ATG AAA GAA ACA AAA CAT CAA 
CAC ACA TTT TCT ATC CGT 
PU2 AAG TCG GCT TAT GGT GCC GCG TCG GTT ATG GTC GCA TCA TGT ATA 
TTT GTC ATC GGT GGG 
PU3  GGC GTG GCA GAG GCA AAT GAT TCG ACA ACA CAA ACA ACG ACA CCA 
CTA GAA GTC GCT CAA 
PU4 ACG TCG CAG CAA GAA ACA CAT ACA CAT CAA ACA CCT GTT ACA TCA 
TTA CAT ACT GCA ACA 
PU5 CCT GAA CAT GTT GAT GAC TCT AAA GAA GCA ACA CCT TTA CCT GAA 
AAA GCA GAG TCA CCA 
PU6 AAA ACC GAA GTG ACA GTT CAA CCT TCA TCG CAT ACA CAG GAA GTA 
CCT GCG TTA CAT AAA 
PU7 AAA ACA CAG CAA CAA CCG GCG TAT AAG GAT AAA ACG GTA CCA GAG 
TCA ACG ATA GCA TCA 
PU8 AAG TCG GTT GAA TCA AAT AAA GCA ACA GAA AAT GAG ATG 
PU9 TCA CCT GTT GAA CAT CAT GCT TCA AAT GTG GAA AAA CGT GAA 
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Table S1. (continued) 
Primer Sequence 5’ to 3’ 
PU10 GAT AGA TTG GAG ACT AAT GAG ACA ACA CCG CCA TCA GTG GAC CGT 
GAA TTT AGC CAT AAA 
 
PU11 ATC ATC AAT AAT ACG CAC GTA AAT CCA AAA ACG GAT GGA CAA ACA 
AAC GTT AAT GTT GAT 
 
PU12 ACG AAA ACG ATA GAC ACC GTT TCA CCG AAA GAT GAC AGA ATA 
GAT ACG GCG CAA CCG AAA 
lipF TAT ATG TAC AAT GAA AGA AAC AAA ACA TCA ACA CAC AT 
lipR TAT AAG ATC TAC TAG TAT TTG CCT CTG CCA CGC C 
lipR2  TAT AAG ATC TAC TAG TTG TTG GTT TTT TGT CGC TCG 
nprEF TAT ATG TAC AAT GGG TTT AGG TAA GAA ATT GTC TG  
nprER TAT AAG ATC TAC TAG TAG CAG CCT GAA CAC CT  
nprER2 TAT AAG ATC TAC TAG TAT GTT CTA CTT TAT TTT GCT GTT TTA AAA  
nprMF TAT ATG TAC A ATGAAAAAGAAAAAACAGGCTTTAAAGG 
nprMR TAT AAG ATC TAC TAG TATG TGC AAA AGC AAA TGA TGA AG 
nprMR2 TAT AAG ATC TAC TAG T AGG TTT CGC TGC CGG C 
phoF TAT AAG ATC TAC TAG TCG GGC TGC TCA GGG CGA TAT 
phoR TAT ACG GCC GTT AGT GAT GGT GAT GGT GGT GTT TCA GCC CCA GAG 
CGG C 
enprEF TAT AAG ACT T ACT AGT GCC GCC GCC ACT GGA AGC  
enprER TAT A CGG CCG TTA GTG ATG GTG ATG GTG GTG CAA TCC AAC AGC 
ATT CCA GGC 
Restriction sites are highlighted in bold letters.  
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Amino acid sequences of pre- and propeptides were investigated in this study 
S. hyicus lipA prepeptide 
M K E T K H Q H T F S I R K S A Y G A A S V M V A S C I F V I G G G V A E A ↓N 
 
S. hyicus lipA prepropeptide 
M K E T K H Q H T F S I R K S A Y G A A S V M V A S C I F V I G G G V A E A 
N D S T T Q T T T P L E V A Q T S Q Q E T H T H Q T P V T S L H T A T P E H V D D S K 
E A T P L P E K A E S P K T E V T V Q P S S H T Q E V P A L H K K T Q Q Q P A Y K D K 
T V P E S T I A S K S V E S N K A T E N E M S P V E H H A S N V E K R E D R L E T N E 
T T P P S V D R E F S H K I I N N T H V N P K T D G Q T N V N V D T K T I D T V S P K D 
D R I D T A Q P K Q V D V P K E N T T A Q N K F T S Q A S D K K P T  
 
B. subtilis nprE prepeptide 
MGLGKKLSVAVAASFMSLSISLPGVQA↓A 
 
B. subtilis nprE prepropeptide 
MGLGKKLSVAVAASFMSLSISLPGVQA 
AEGHQLKENQTNFLSKNAIAQSELSAPNDKAVKQFLKKNSNIF 
KGDPSKRLKLVESTTDALGYKHFRYAPVVNGVPIKDSQVIVHVDKSDNVYAVNGELHN
QSAAKTDNSQKV 
SSEKALALAFKAIGKSPDAVSNGAAKNSNKAELKAIETKDGSYRLAYDVTIRYVEPEPA
NWEVLVDAETG 
SILKQQNKVEH 
 
B. megaterium nprM prepeptide 
MKKKKQALKVLLSVGILSSSFAFA↓H 
B. megaterium nprM prepropeptide 
M K K K K Q A L K V L L S V G I L S S S F A F A 
H T S S A A P N N V L S T E K Y N K E I K S P E F I S G K L S G P S S Q K A Q D V V F H 
Y M N T N K D K Y K L G N E N A Q N S F K V T E V V K D P V E Q A T V V R L Q Q V 
Y N N I P V W G S T Q L A H V A K D G T L K V V S G T V A P D L D K K E K L K G Q K 
Q V D S K K A I Q A A E K D L G F K P T Y E K S P S S E L Y V Y Q N G S D T T Y A Y V 
V N L N F L S P E P G N Y Y Y F V D A I S G K V L D K Y N T I D S V A G P K A D V K Q 
A A K P A A K P 
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CHAPTER FIVE 
ISOLATION OF HIGH CONTENT METHIONINE-CONTAINING BACTERIA AND 
CHARACTERIZATION OF METHIONINE PRODUCTION 
  
ABSTRACT 
Methionine is the first limiting amino acid in poultry feed. Currently methionine 
supplement is synthesized from a chemical process and it is anticipated that it will soon not be 
allowed for use by organic poultry industry Therefore, the objectives of this study were isolation 
of methionine producing bacteria from environmental samples and quantification of methionine 
production in these isolated bacteria. MCGC medium was selected as the isolation medium for 
methionine-producing bacteria by using Corynebacterium glutamicum ATCC13032 and E. coli 
ATCC23798 as the positive and negative controls, respectively. Thirty-nine bacterial strains 
were obtained from environmental samples. Only strains A121, A122, A151, and A181 were 
able to tolerate upto 0.1% (w/v) of ethionine or norleucine. These isolated strains were identified 
by sequencing small subunit rRNA genes. The results revealed that bacterial strains A121, A122, 
A151and A181 were Klebsiella species, Acinetobacter baumannii, A. baumannii and 
Pseudomonas aeruginosa, respectively. When methionine production in strains A121 and A181 
was quantitated, under these conditions strains A121 and A181 excreted methionine up to 31.109 
and 124.578 µg/ml, respectively.  
  
KEY WORDS: bacteria, ethionine, methionine production, norleucine,  
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INTRODUCTION 
Methionine is a nutritionally essential amino acid required in the diets of humans and 
livestock, including poultry. Approximately 90% of poultry feed is composed of corn and 
soybean both of which are insufficient for methionine requirement and it is therefore one of the 
first limiting amino acids in poultry feed (Baker, 2009). Methionine deficiency has been linked 
to development of various diseases and physiological conditions in animals. Currently, 
methionine supplements in animal feed are produced either by chemical synthesis or by 
hydrolyzing proteins. These processes are expensive and require hazardous chemicals (Fong et 
al., 1981). Synthetic methionine is currently allowed as an additive to organic poultry feed by the 
U.S. Department of Agriculture’s National Organic Program (NOP) however NOP is only 
extending its use until October 1st 2012 (USDA, Agricultural Marketing Service, 
http://www.paorganic.org/wp-content/uploads/2011/10/USDA-Methionine.pdf).  Therefore, 
there is an urgent need for organic sources of methionine for feed additives. 
Many studies have attempted to isolate methionine producing bacteria from environments 
or generate genetically modified organisms by using N-methyl-N′-nitro-N-nitrosoguanidine. 
Several studies have reported that methionine-analog resistance in bacterial strains correlated to 
higher methionine production due to an alteration in the regulation of L-methionine biosynthesis 
(Adelberg, 1958; Chattopadhyay et al., 1991; Yamada et al., 1982). Although the mutation was 
successful in producing methionine over-producing microorganisms, any genetically-modified 
organisms are considered unacceptable for use in organic food production (Electronic Code of 
Federal Regulations: U.S. National Organic Program).  Therefore, wild type strains with 
methionine-producing ability are necessary for the organic poultry industry. The aims of this 
 111 
study were to isolate methionine-producing bacteria and to quantify methionine production from 
these strains. 
MATERIALS AND METHODS 
Bacterial strains 
 Corynebacterium glutamicum ATCC13032 and E. coli ATCC23798 were obtained from 
American Type Culture Collection (ATCC, Manassas, VA). In this study, C. glutamicum 
ATCC13032 and E. coli ATCC23798, a methionine auxotroph, were used as positive and 
negative controls respectively, for selective medium of methionine production.  
Selection of isolation medium for detection of methionine-containing bacteria 
 For selection of isolation medium, C. glutamicum was cultured for one day and E. coli 
was cultured overnight in Luria-Bertani (LB) broth at 37oC in a waterbath shaker (NBS C76, 
New Brunswick Scientific Co., Inc., Edison, NJ). Ten ml of the cultures were centrifuged (10000 
x g, 10 min, 4oC), washed twice with 10 ml of 0.9% NaCl, and re-suspended in 10 ml of 0.9% 
NaCl. Both strains were re-streaked on LB agar, basal medium agar (Kase and Nakayama, 1974), 
and MCGC agar (von der Osten et al., 1989). The agar plates were incubated at 37oC for at least 
one day. The medium which showed growth of C. glutamicum while inhibiting the growth of E. 
coli was used in further studies to isolate methionine producing bacteria. 
Isolation of methionine-containing bacteria 
The sample sources included nine chicken intestinal contents, six soil samples, one water 
sample from Scull Creek, Fayetteville, AR, one from fresh horse manure, one from compost, and 
one from bovine rumen fluid. The nine chicken intestinal contents were obtained from 5 – week-
old broilers (conventional straight-run/off-sex) maintained on conventional corn/soy feed. Each 
sample, except the water and bovine rumen fluid samples, was mixed with 25-ml normal saline 
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solution and a 0.5-ml suspension was inoculated into 4.5-ml MCGC broth incubated under both 
aerobic and anaerobic incubation conditions. Water and bovine rumen fluid samples were added 
directly into 4.5-ml MCGC broth. Samples were incubated at 37oC in a waterbath shaker or in an 
anaerobic jar with a commercial anaerobic culture system (AnaeroPack, Mitsubishi Gas 
Chemical Co. Inc., Tokyo, Japan), respectively. For eight consecutive days, the 1/100 volume of 
inocula was transferred into fresh MCGC broth.  The mixed cultures were 10-fold diluted or 
streaked onto MCGC agar plates. Different morphological colonies were picked from each 
sample and transferred into MCGC broth.  
Methionine feedback effect assay 
The bacterial strains which grew on MCGC agar plates were subsequently cultured on 
MCGC agar plates containing 0.1% (w/v) norleucine, a methionine analog.  Strains that grew 
well in the presence of 0.1% (w/v) norleucine were retained for further evaluations.  C. 
glutamicum ATCC13032 was used as the positive control. C. glutamicum ATCC13032 and eight 
isolated strains were cultured on MCGC broth supplied with either ethionine or norleucine at 
0.05 and 0.1% (w/v) on a 96-well plate. The 96-well plates were incubated in a Tecan Infinite 
M200 (San Jose, CA) at 37 oC for 24 hours and the optical density was measured every hour at 
600 nm.  
Identification of potential methionine-containing microorganisms 
The methionine over-producing bacterial strains which grew in the presence of 0.1% 
(w/v)  norleucine were identified by sequencing the small subunit rRNA (SSU rRNA).  The SSU 
rRNA sequences of methionine over-producing bacteria were amplified by using primers 27F 
and 1492R as described in Schuurman et al. (2004). The thermal cycling profile was as follows: 
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2 min at 95oC, followed by 30 cycles of 30 s at 95oC, 30 s at 50oC, 2 min at 72oC, followed by 10 
min at 72oC.   
The PCR products were sequenced by the DNA Resource Center, University of 
Arkansas, Fayetteville, AR. The resulting consensus sequence, created from the double-stranded 
part of the alignment, was used for comparison with sequences stored in GenBank, by using the 
basic local alignment search tool (BLAST; http://www.ncbi.nlm.nih.gov/BLAST/) (Altschul et 
al., 1990) and the similarity matrix tool from the Ribosomal Database Project II (RDP-II; 
http://rdp.cme.msu.edu/html/analyses.html) (Cole et al., 2003). For both BLAST and RDP-II 
analyses, the highest-scoring species was reported. 
Measurement of growth 
 The potential methionine-overproducing strains were cultured in MCGC medium at 
37oC, 200 rpm for 12 hours. A 1/100 volume of cells was transferred into 50-ml fresh medium in 
three-baffled 500-ml flasks and cells were maintained under the same conditions until late log 
phase. The turbidity of the culture was read at 600 nm.  
Methionine quantification by microbial assay 
Bacterial strains A121 and A181 were cultured on MCGC medium until late log phase. 
Cells were collected by centrifugation at 14,000 x g, 4oC for 10 min and were washed three times 
with the same volume of 0.9% NaCl solution. For cell digestion, 1 ml of 0.1 N HCl was added 
into each sample and the samples stood at 110 oC for 1 hour.  These samples were kept at 4 oC. 
Methionine quantification was measured by using E. coli K12 with a partial metC 
deletion. To construct a methionine auxotrophic strain, the target metC region was amplified by 
PCR with primers UF2 and LR2.  The 708 bp out of 1188 bp-metC gene in E. coli K12  was 
deleted by following the manufacture protocol (Quick and Easy E. coli Gene Deletion Kit, Gene 
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Bridges, Heidelberg, Germany).  The E. coli K12 derivative with metC partially deleted was 
designated as strain K12C. A correct partial metC deletion on the chromosome of E. coli K12C 
was verified by PCR with primers CF6 and CR6. The thermal cycling profile was as follows: 2 
min at 95 oC, followed by 30 cycles of 30 s at 95 oC, 30 s at 55 oC, 4 min at 72 oC, followed 
finally by 10 min at 72 oC.   
E. coli K12C was cultured in Luria-Bertani medium at 37 oC, 200 rpm for 5 hours and 
then was harvested by centrifugation at 5,000 x g, 4 oC for 5 min and washed three times by 
MCGC medium (von der Osten et al., 1989). The cells were diluted 1/100 with fresh MCGC 
medium and methionine concentrations between 0 to 500 µg/ml were used as the standard. E. 
coli cells with various methionine concentrations and samples were added into the 96-well plates 
incubated in Tecan Infinite M200 (San Jose, CA) at 37 oC for 24 hours and the optical density 
was measured every hour at 600 nm.  
Statistical analyses 
Where standard deviations are presented in the respective figures, these values represent 
the average of at least triplicate measurements. The statistical tests for treatment effects were 
performed using an analysis of variance (ANOVA) procedure of Statistixs 9.1 Analytical 
Software (SAS Institute, Cary, NC). Means were further separated using least-significant 
difference multiple comparisons. 
RESULTS 
Selection of isolation medium for detection of methionine- containing bacteria 
  C. glutamicum ATCC13032 and E. coli ATCC23798 were cultured on basal medium 
and LB medium as the positive control medium. However, both bacteria were unable to grow on 
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basal medium agar. C. glutamicum ATCC13032 grew well on MCGC and LB agars while E. coli 
ATCC23798 grew only on LB agar. Therefore, MCGC agar was used in future steps.  
Isolation and identification of methionine over-producing bacteria 
As shown in Table 5.2, 38 bacterial strains were isolated from environmental samples. 
All strains in this study were able to grow under both aerobic and anaerobic conditions. All 
strains including C. glutamicum ATCC13032 were cultured on MCGC agar containing 0.1% 
norleucine (w/v). Only C. glutamicum ATCC13032, and strains A101, A111, A121, A122, 
A131, A151, A171, and A181 grew well on MCGC agar supplied with norleucine at 0.1% (w/v).  
The strains that could grow in the presence of norleucine at 0.1% (w/v) on MCGC agar 
were further assayed on MCGC broth containing either ethionine or norleucine at 0.05 or 0.1% 
(w/v). The results showed that the types and concentrations of methionine analogs significantly 
affected the growth of these bacterial isolates (Fig. 5.1 to 5.9). Based on the results from strains 
ATCC13032 and A171 cultured in MCGC broth supplied with two methionine analogs, 
ethionine had significantly (P < 0.05) higher inhibitory ability to the growth than norleucine (Fig. 
5.1 and 5.8). However, the growth of strains A122. , A151, and A181 with ethionine supplement 
was significantly (P < 0.05) higher than the growth without methionine analog addition (Fig. 5.5, 
5.7, and 5.9). Overall, from 39 isolated bacterial strains and C. glutamicum ATCC13032, only 
bacterial strains C. glutamicum ATCC13032, and isolates A101, A111, A121, A122, A131, 
A151, A171, and A181 could tolerate norleucine at 0.1% (w/v) in MCGC agar (Table 5.1). By 
culturing 9 bacterial strains in MCGC broth containing either ethionine or norleucine at 0.05 and 
0.1% (w/v), only strains A121, A122, A151, and A181 were able to grow well under these 
conditions.  
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By using the primers 27F and 1492R, a universal primer set for the domain Bacteria, 
approximately 1500 bp DNA fragments were obtained. Based on the comparison from BLAST 
and RDP-II, both databases unanimously confirmed these organisms at least at the genus level. 
The SSU rRNA sequences of strain A121, A122, A151, A171 and A181 were matched with 
Klebsiella species, Acinetobacter baumannii, A. baunnii, Pantoea species, and Pseudomonas 
aeruginosa, respectively.  
Methionine quantification 
 The characterization of strains A121 and A181 was continued to evaluate the correlation 
between methionine-analog resistance and methionine biosynthesis. The growth of both strains 
were cultured on MCGC medium at 37 oC, 200 rpm (Fig 5.10) and the samples were collected to 
measure methionine biosynthesis at different time intervals (Table 5.2). The methionine in cell 
samples slightly increased between 4 to 12 hour incubation (Table 5.2). However, total 
methionine samples from both were much higher than the cell methionine samples. While 
methionine in cell samples of strain A181 was increased from 6.122 µg/ml at 4 hour incubation 
to 31.109 µg/ml at 12 hour incubation, the total methionine was increased from 63.200 to 
124.578 µg/ml during that the same time period.  
DISCUSSION 
Methionine is the first limiting amino acid in poultry feed. Methionine supplementation 
in poultry production enhances feed efficiency, increases protein synthesis, and improves 
immune systems (Bunchasak, 2009).  Dietary supplementation of methionine at 5.4 g/kg has 
been shown to improve color, water-holding capacity, and oxidative stability of male offspring 
meat (Wang et al., 2009). For long-term benefits, adequate methionine is considered necessary 
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for sustaining normal immunocompetence and achieving maximum egg production in laying 
hens in subtropical climates (Poosuwan et al., 2010).   
Methionine production has been manufactured synthetically for more than 50 years 
(Leuchtenberger et al., 2005); however,  synthetic methionine soon will no longer be allowed in 
organic poultry feed production (USDA, Agricultural Marketing Service, 
http://www.paorganic.org/wp-content/uploads/2011/10/USDA-Methionine.pdf). However, 
methionine biosynthesis from wild-type microorganisms could serve as an alternative way to 
support the organic poultry industry. In this study, bacterial strains were isolated from 
environmental samples and selected methionine over-production by using two methionine 
analogs.   
Isolation of methionine-containing microorganisms 
 Minimal media without methionine were used to culture C. glutamicum ATCC13032 and 
E. coli ATCC23798 as the positive and negative controls in this study. Only the methionine-
producing bacteria C. glutamicum was able to grow on MCGC medium; thus the MCGC 
medium was used as the selective medium for isolating methionine-producing bacteria.  The 
inability of C. glutamicum ATCC13032 to grow on the basal medium may be due to the buffer 
capacity of the medium (Lawrence et al. 1968). Unlike the buffer capacity of basal medium, the 
buffer capacity of MGCG medium increases during fermentation as the pH of the culture 
decreases (von der Osten et al., 1989).  
Identification of potential methionine-overcontaining microorganisms 
In this study, 38 isolated strains and C. glutamicum ATCC13032 were cultured with 
methionine analogs for methionine over-production. Finally, 5 bacteria were identified by 
sequencing SSU rRNA genes. However, all 5 strains were potential plant and human pathogens 
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which are impractical for methionine production. The SSU rRNA gene of strain A121 isolated 
from a water sample was matched with Klebsiella species, this genus has been recovered from 
aquatic environments (Grimont and Grimont, 2001) while the SSU rRNA genes of strains A122 
and strain A151 isolated from a water sample and a compost sample, respectively, were a match 
with A. baumannii, a bacterium that occurs naturally in soil and water (Juni, 2001). Strain A171 
originating from a soybean field at the University of Arkansas belongs to the genus Pantoea, the 
genus generally associated with plants (Delétoile et al., 2009), while strain A181 isolated from 
bovine rumen fluid was identified as P. aeruginosa, a ubiquitous bacterium found in the ovine 
rumen (Duncan et al., 1999).  
Methionine production from isolated microorganisms 
Methionine detection methods have been developed by using chemical and biological 
means. For example, Pediococcus acidilactici ATCC8042 was employed as a biological 
approach to methionine detection (Steele et al., 1949). However, the methionine assay medium 
for P. acidilactici ATCC8042 is commercially unavailable and medium preparation is laborious. 
In addition, trace amounts of methionine can cause an error of results. Compared to the method 
based on P. acidilactici ATCC8042, the method based on E. coli K12C in this study was simple 
and the lowest detectable concentration was 5 µg/ml. The information available on E. coli 
ATCC23798 in The Coli Genetic Stock Center at Yale University cited only met-59 and does not 
show which gene in methionine biosynthesis pathway was deleted. The metC was chosen for 
deletion because no bypass occurs at this step (Lee and Hwang, 2003). In addition, due to well 
known genetics, simple media requirement and rapid growth, E. coli auxotroph is a good 
candidate for quantification of amino acid bioavailability (Froelich and Ricke, 2005; Chalova et 
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al., 2010). By When comparing E. coli as a biosensor bioassay with an animal bioassay, lysine 
bioavailability of feed samples were not significantly different (Chalova et al., 2007).  
By using two methionine analogs in this study, strain A181 which was more tolerant to 
these analogs produced more methionine. In addition, both strains excreted methionine into the 
surrounding media. In general, most methionine-producing bacteria secrete methionine 
externally. Ghosh and Banerjee (1986) reported Serratia marcescens under some conditions 
secreted methionine at approximately 100 µg/ml.  
In this study, all identified strains were pathogens. For safety reasons, it might be better 
to  isolate methionine-producing bacteria from specific food samples such as yoghurt and starter 
culture producers may represent a better approach.  For example, Cebeci and Gurakan (2008) 
studied methionine biosynthesis in Lactobacillus delbrueckii subsp. bulgaricus and 
Streptococcus thermophilus. In addition, molecular approaches might be useful for methionine 
biosynthesis detection. Since methionine biosynthesis pathways are variable in different 
organisms (Lee and Hwang, 2003), it is difficult to design specific primers for detecting 
methionie biosynthesis. However, Cebeci and Gurakan (2008) were successful to design primers 
for detecting methionine genes in L. delbrueckii subsp. bulgaricus and S. thermophilus due to 
95% similarity of methionine biosynthesis gene in both organisms.  
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Table 5.1. Primers used in this study. 
 
Primer 
 
Sequence  
UF2 
 
TGCAGCCAAACACTAAAATCGTGTTTCTGGAATCGCCAGGCTCCATCAC
CAATTACCCTCACTAAAGGGCGa 
LR2 
 
GTTGAAAAACTGGAAGCGGCGGTTTGGCAGACCGGAAATTCCCGCCATG
GTAATACGACTCACTATAGGGCTC 
CF6  ACAATACCTGCGCTGCAACATCAC 
 
CR6 CGATGTGCGTTTGTTGTATGGCGA 
 
aItalics show sequences for amplification of the FRT-PGK-gb2-neo-FRT cassette 
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Table 5.2.  The bacterial isolates were grown in either aerobic or anaerobic condition and with 
norleucine at 0.1 % (w/v).    
 Strains isolated under a aerobic 
condition 
Strains isolated under an anaerobic condition 
Sample 
source 
strain Grow with 
norleucine a 
strain Grow with 
norleucine in 
a aerobic 
condition  
Grow with 
norleucine in 
an anaerobic 
condition 
 C. glutamicum 
ATCC13032b, c 
3+    
chicken 
intestinal 
contents 
A11d - AA11e - - 
chicken 
intestinal 
contents 
A21 - AA21 - - 
chicken 
intestinal 
contents 
A31 - AA31 - - 
chicken 
intestinal 
contents 
A41 - AA41 - - 
A42 -    
chicken 
intestinal 
contents 
  AA51 - - 
chicken 
intestinal 
contents 
A61 1+ AA61 - - 
A62 -    
chicken 
intestinal 
contents 
A71 - AA71 - - 
chicken 
intestinal 
contents 
A81 1+ AA81 - - 
chicken 
intestinal 
contents 
A91 - AA91 - - 
Soil samplef A101 3+ AA101 1+ - 
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Table 5.2.  (continued).   
 
 Strains isolated under a 
aerobic condition 
Strains isolated under an anaerobic condition 
Sample 
source 
strain Grow with 
norleucine a 
strain Grow with 
norleucine in 
a aerobic 
condition  
Grow with 
norleucine in 
an anaerobic 
condition 
Soil sampleg A111 3+ AA111 1+ 1+ 
Water  A121 3+ AA121 - - 
sampleh A122 2+    
Soil samplei A131 3+ AA131 1+ - 
Horse 
manurej 
A141 - AA141 1+ - 
Compost A151 - AA151 - - 
   AA152 1+ - 
Soil samplek A161 - AA161 1+ 1+ 
Soil samplel A171 3+    
Bovine rumen 
fluidm 
 
A181 3+ AA181 1+ - 
a Growth with norleucine was monitored on agar plate under a aerobic condition. The best, 
medium, and poor levels of growth are 3+, 2+, and 1+, respectively. No growth on agar plates 
was (-).  
b C. glutamicum ATCC13032 as the positive control. 
c only C. glutamicum ATCC13032 was unable to grow on both LB agar (enriched medium) and 
MCGC agar (minimal medium) under an anaerobic condition.  
d A11 was isolated under a aerobic condition from the first sample and the first type strain.  
e AA11 was isolated under an anaerobic condition from the first sample and the first type strain. 
f Soil sample was collected from the bamboo root.  
g Soil sample was collected from lawn at Chestnut apartment, Fayetteville, AR 
h Water sample  was collected from Scull Creek, Fayetteville, AR. 
i Soil sample was collected from Scull Creek, Fayetteville, AR. 
j The manure was collected from an American Quarter horse grazing mixed grasses.  
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k Soil sample was collected from roadside at Morning Side Rd., Fayetteville, AR. 
l Soil sample was collected from soybean field at University of Arkansas, Fayetteville, AR. 
m Rumen fluid was collected from Gelbveih Angus Cross grazing Bermuda grass.   
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Table 5.3.  Methionine production in bacterial samples (µg/ml). 
Samples Incubation time (hours) 
4 6 8 10 12 
Cells 
methionine in 
strain A121 
7.86 ± 1.62a 3.34 ± 2.61  4.56 ± 1.29  NDb ND 
Cells 
methionine in 
A181 
6.12 ± 0.90 10.24 ± 1.98  17.91 ± 0.63  13.94 ± 4.58  31.11 ± 13.26 
Total 
methionine in 
strain A121 
44.13 ± 2.17  64.22 ± 3.87  78.93 ± 16.22 ND ND 
Total 
methionine in 
A181 
63.20 ± 9.91 90.44 ± 7.63 102.62 ± 
30.05 
73.33 ± 35.47 124.58 ± 
33.20  
aThe mean of methionine production (µg/ml) and standard deviations. 
 
bND, not determined. 
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Fig. 5.1 The growth of bacterial strain ATCC13032. The strain was culture on MCGC medium 
containing either ethionine or norleucine at 0.05 and 0.1% (w/v). a.b,c,d,e Means within the same 
growth measurements with unlike superscripts (P < 0.05). Error bars indicate standard deviations 
between growth measurements. 
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Fig. 5.2 The growth of bacterial strain A101. The strain was culture on MCGC medium 
containing either ethionine or norleucine at 0.05 and 0.1% (w/v). a.b,c,d,e Means within the same 
growth measurements with unlike superscripts (P < 0.05). Error bars indicate standard deviations 
between growth measurements. 
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Fig. 5.3 The growth of bacterial strain A111. The strain was culture on MCGC medium 
containing either ethionine or norleucine at 0.05 and 0.1% (w/v). a.b,c,d,e Means within the same 
growth measurements with unlike superscripts (P < 0.05). Error bars indicate standard deviations 
between growth measurements. 
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Fig. 5.4 The growth of bacterial strain A121. The strain was culture on MCGC medium 
containing either ethionine or norleucine at 0.05 and 0.1% (w/v). a.b,c,d,e Means within the same 
growth measurements with unlike superscripts (P < 0.05). Error bars indicate standard deviations 
between growth measurements. 
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Fig. 5.5 The growth of bacterial strain A122. The strain was culture on MCGC medium 
containing either ethionine or norleucine at 0.05 and 0.1% (w/v). a.b,c,d,e Means within the same 
growth measurements with unlike superscripts (P < 0.05). Error bars indicate standard deviations 
between growth measurements. 
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Fig. 5.6 The growth of bacterial strain A131. The strain was culture on MCGC medium 
containing either ethionine or norleucine at 0.05 and 0.1% (w/v). a.b,c,d,e Means within the same 
growth measurements with unlike superscripts (P < 0.05). Error bars indicate standard deviations 
between growth measurements. 
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Fig. 5.7 The growth of bacterial strain A151. The strain was culture on MCGC medium 
containing either ethionine or norleucine at 0.05 and 0.1% (w/v). a.b,c,d,e Means within the same 
growth measurements with unlike superscripts (P < 0.05). Error bars indicate standard deviations 
between growth measurements. 
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Fig. 5.8 The growth of bacterial strain A171. The strain was culture on MCGC medium 
containing either ethionine or norleucine at 0.05 and 0.1% (w/v). a.b,c,d,e Means within the same 
growth measurements with unlike superscripts (P < 0.05). Error bars indicate standard deviations 
between growth measurements. 
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Fig. 5.9 The growth of bacterial strain A181. The strain was culture on MCGC medium 
containing either ethionine or norleucine at 0.05 and 0.1% (w/v). a.b,c,d,e Means within the same 
growth measurements with unlike superscripts (P < 0.05). Error bars indicate standard deviations 
between growth measurements. 
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Fig.5.10. The growth of bacterial strains A121 and A181cultured on MCGC medium at 37 oC, 
200 rpm. The growth measurements were measured at 600 nm and were performed with at least 
three independent cultures. Error bars indicate standard deviations between growth 
measurements. 
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CHAPTER SIX 
ISOLATION OF HIGH METHIONINE-CONTAINING YEAST  
UTILIZING METHIONINE ANALOGS 
   
ABSTRACT 
Methionine is one of the first limiting amino acids in poultry nutrition and typically in 
most diets this amino acid has to be supplemented into the poultry feed mixture. It is anticipated 
that in the near future the organic poultry industry will not be allowed to add synthetic 
methionine generated from chemical synthesis to diets of birds. Therefore, the objectives of this 
study were identification of high content methionine containing yeasts and quantification of 
methionine content in yeasts. Minimal medium was used as the selection medium and the 
isolation medium of methionine-producing yeasts from yeast collection and environmental 
samples, respectively. Two out of the eleven yeasts previous collected and six additional strains 
were isolated from Caucasian kefir grains, air-trapped, cantaloupe, and three soil samples that 
could grow on minimal medium. Only two of the newly isolated strains K1 and C1 grew better 
than others in minimal medium supplied with either ethionine or norleucine at 0.5% (w/v). Based 
on large subunit rRNA sequences, these isolated strains were identified as Pichia 
kudriavzevii/Issatchenkia orientalis. P. kudriavzevii/I. orentalis is recognized as a ″generally 
recognized as safe″ (GRAS) organism. In addition, methionine produced by K1 and C1 yeast 
hydrolysate could be measured by microbial assay and yielded 19.30 mg per gram dry cell. Yeast 
strain K1 may be suitable as a source of methionine for dietary supplements in organic poultry 
feed. 
KEY WORDS: ethionine, methionine production, norleucine, yeast 
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INTRODUCTION 
Methionine is an essential amino acid for proper growth and development of chickens.  
Chickens are unable to produce methionine and therefore must obtain it externally as a dietary 
supplement. However, in the U.S., approximately 90% of poultry feed is composed of corn and 
soybean but both are insufficient to meet the birds’ methionine requirement and it is therefore 
one of the first limiting amino acids in poultry feed (Baker, 2009). The organic poultry industry 
faces an even greater challenge regarding methionine supplementation in organic poultry feed.  
Currently available organic poultry feed contains insufficient amounts of methionine resulting in 
reduced broiler growth rates (Rodenburg et al., 2008) as well as lower egg weights for laying 
hens (Elwinger et al., 2008).   
Current methods of methionine production include either de novo chemical synthesis or 
by hydrolysis of proteins. Both methods are expensive and require the use of hazardous 
compounds (Kumar and Gomes, 2005).  Synthetic methionine is currently allowed as an additive 
to organic poultry feed by the U.S. Department of Agriculture’s National Organic Program 
(NOP) however NOP is only extending its use until October 1st 2012 (USDA, Agricultural 
Marketing Service, http://www.paorganic.org/wp-content/uploads/2011/10/USDA-
Methionine.pdf).  Therefore, there is an urgent need for organic sources of methionine for feed 
additives. 
Many attempts have been made to utilize yeast cells as protein sources in livestock and 
aquaculture industries.  For example, Candida utilis is widely used for animal feed as a protein 
source because it is able to grow on inexpensive substrates (Demain et al., 1998). Gilter et al. 
(1958) reported that torula yeasts could replace fish meal up to 25% without influencing the rate 
of growth in chickens. Recently, Garcia-Hernandez et al. (2012. 
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doi:101.1016/j.rvsc.2011.09.005) isolated yeasts from the excreta of broilers and found that some 
strains have potential as probiotic supplements. However, yeast hydrolysate used as a protein 
source in animal feed has been shown to be insufficient as a source of methionine (Komatsu et 
al., 1974; Rastogi and Murti, 1964). To improve methionine content, mutagenesis by UV 
irradiation or administering N-methyl-N’-nitro-N-nitrosoguanidine have been used to select 
methionine-analog resistant mutants that are characterized by greater methionine biosynthesis 
(Brigidi et al., 1988; Dunyak and Cook, 1985; Komatsu et al., 1974; Morzycka et al., 1976; 
Musilkova and Fencl, 1964; Tani et al., 1988). However, based on USDA regulations, the 
organic poultry industry will not be allowed to use methionine supplements from chemical 
production systems after October 1st, 2012. The objective of this study was to identify high 
content methionine containing yeast for potential use in the organic poultry industry; utilizing 
methionine analogs to screen methionine overproduction in wild-type yeasts.  
MATERIALS AND METHODS 
Isolation of methionine producing yeast 
In this study, eleven yeast strains were provided by Professor Ines Pinto, Department of 
Biological Sciences, University of Arkansas, Fayetteville, AR (Table 6.1). An additional six 
yeast strains were isolated from a variety of environmental samples.  Air-trapped yeast cells were 
prepared by mixing all purpose flour and water. The air-trapped yeast sample and cantaloupe 
were allowed to stand in an open-environment for 10 hours. All environmental samples were 
inoculated into minimal medium (Table 6.2) (Morzycka et al., 1976). The cultures were 
maintained at 30oC, 200 rpm in a shaker (incubator model G-25, New Brunswick Scientific, New 
Brunswick, NJ) and were transferred to fresh media for eight consecutive days.   
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Methionine feedback effect assay 
For screening of methionine-overproducing yeast, each strain was assayed on minimal 
medium containing either ethioine or norleucine at 0.5% (w/v).  The 96-well plates were 
incubated in a Tecan Infinite M200 (San Jose, CA) at 30oC for 24 hours and the optical density 
was measured every hour at 580 nm.  
Measurement of yeast growth 
 The potential methionine-overproducing yeast strain was cultured in both minimal 
medium and lactose medium (Table 6.2) (Lukondeh et al., 2005) at 30oC, 200 rpm overnight. A 
1/100 volume of yeast cells was transferred into 50-ml fresh medium in three-baffled 500-ml 
flasks and these cells were maintained under the same conditions until reaching stationary phase. 
The turbidity of the culture was read at 580 nm (Tecan Infinite M200, San Jose, CA).  
Methionine quantification  
Yeast strain K1 and C1 were cultured in minimal and lactose media until late log phase. 
Yeast cells were collected by centrifugation at 14,000 x g, 4oC for 10 min and were washed three 
times with the same volume of 0.9% NaCl solution. In this study, yeast samples were first 
hydrolyzed by acid and were subsequently detected by microbiological assay similar to the other 
studies (Kitamoto and Nakahara, 1974; Komatsu et al., 1974). For cell digestion, 1 ml of 6 N 
HCl was added into each sample and the samples allowed  to stand at 110oC for 1 hour.  These 
samples were kept at 4 oC and the samples were diluted 10 fold by 0.1 N HCl before being 
quantified.  
E. coli K12 was obtained from the E. coli Genetic Stock Center, Yale University School 
of Medicine, New Haven, CT. A part of metC gene was deleted by using Quick and Easy E. coli 
Gene Deletion Kit (Gene Bridges, Heidelberg, Germany) and designated as E. coli K12C.   E. 
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coli K12C was cultured in Luria-Bertani medium at 37 oC, 200 rpm for 5 hours and was 
subsequently harvested by centrifugation at 5,000 x g, 4 oC for 5 min and washed three times by 
MCGC medium (von der Osten et al., 1989). The cells were diluted 1/100 with fresh MCGC 
medium and methionine concentrations between 0 to 500 µg/ml were used as the standard. E. 
coli cells with various methionine concentrations and samples were added into the 96-well plates 
and incubated in a Tecan Infinite M200 (San Jose, CA) at 37 oC for 24 hours and the optical 
density was measured every hour at 600 nm.  
Identification of potential methionine-producing yeasts 
The large subunit rRNA (LSU rRNA) genes of methionine over-producing yeast strains 
were amplified by using primers NL-1 and NL-4 as described in Kurtzman and Robnett (1998). 
The thermal cycling profile was as follows: 2 min at 95oC, followed by 30 cycles of 30 s at 95oC, 
30 s at 52oC, 1 min at 72oC, followed by 10 min at 72oC.  
The PCR products were sequenced by the DNA Resource Center, University of 
Arkansas, Fayetteville, AR. The partial LSU rRNA sequence of K1 was used to query GenBank.  
To place K1 within a phylogeny of representative yeasts, sequences from GenBank were 
included in the analysis. The alignment was generated and a neighbor joining tree was 
constructed using CLC genomics workbench 4.0.3 employing the default settings for nucleotide 
data. The tree was subjected to 1,000 replicates of bootstrapping, and the percentages of 
replicates supporting a given node are indicated in Fig. 6.9. 
Statistical analyses 
Where standard deviations are presented in the respective tables and figures, these values 
represent the average of at least triplicate measurements. The statistical tests for treatment effects 
were performed using an analysis of variance (ANOVA) procedure of Statistixs 9.1 Analytical 
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Software (SAS Institute, Cary, NC). Means were further separated using least-significant (P < 
0.05) difference multiple comparisons. 
RESULTS 
Only Sacchaeomyces(Sac.) cerevisiae ATCC4126 and C. kefyr ATCC2512 out of eleven 
strains from a yeast collection at the University of Arkansas were able to grow in minimal 
medium. Six strains were isolated from Caucasian Kefir grains, air-trapped, cantaloupe, and 
three soil samples. Sac. cerevisiae ATCC4126, C. kefyr ATCC2512 and five strains isolated 
from environmental samples were further tested in yeast minimal medium containing 0.5% (w/v) 
either ethionine or norleucine. For safety reasons, since strain Y1, isolated from air-trapped 
sample was identified as C. parasilosis and is considered a human pathogen, it was discarded 
from further evaluations. 
To further select the high content methionine containing yeasts, seven strains were 
cultured in minimal medium containing either ethionine or norleucine at 0.5% (w/v) (Fig. 6.1 to 
6.7). Compared to cultures without methionine-analogs and norleucine supplement, ethionine 
addition affected the growth of all five strains. Methionine analogs significantly (P < 0.05) 
inhibited the growth of most strains, except strain S2. The growth of all strains supplied with 
ethionine was significantly lower than the growth with norleucine supplement. Surprisingly, 
norleucine enhanced (P < 0.05) the growth in strain S2 but ethionine completely inhibited the 
growth (Fig. 6.6). Strains K1 and C1 were further evaluated since both had greater ability to 
tolerate norleucine and ethionine than the other isolates (Fig. 6.1 and 6.4).  
The biomass from both strains K1 and C1 showed that these organisms preferred to grow 
in minimal media rather than lactose media (Fig. 6.8 and Table 6.3). While dry cell weight 
cultured on minimal medium was approximately 1.4 mg per ml culture, biomass from lactose 
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medium was approximately 0.2 mg per ml (Table 6.3). Methionine biosynthesis from C1 
cultured in lactose medium was 15.3 mg per g dry cell weight, but methionine concentrations 
from cultures in lactose were not detectable (Table 6.3). Methionine concentrations when strain 
K1 was cultured in lactose medium and minimal medium were 9.3 and 19.3 mg per g dry cell 
weight, respectively. Overall, minimal medium supported more growth and methionine 
production in both strains than lactose medium. Based on the phylogenetic analysis, the LSU 
rRNA sequences of strains K1 and C1 were determined to be Pichia kudriavzeii/Issatchenkia 
orientalis (Fig.6.9).  
DISCUSSION 
Methionine is an important amino acid for the poultry industry.  Methionine 
supplementation prevented broiler chicks from developing neurological symptoms when raw 
grass pea seeds (Lathyrus sativus) were used as protein and energy sources in the diet (Fikre et 
al., 2010).  In addition, methionine in diets enhanced the oxidative stability, increased color 
stability, and decreased drip loss in chicken meat (Wang et al., 2009).  In addition, sufficient 
methionine levels in the diet have been demonstrated to be necessary for sustaining normal 
immunocompetence and achieving maximum egg production in laying hens in subtropical 
conditions (Poosuwan et al., 2010).  Bunchasak and Silapasorn (2005) reported that laying hens 
under tropical conditions fed a low-protein diet (14 % crude protein) supplemented with 0.44% 
methionine improved egg production and egg weight.  In the same study bird mortality was 
reduced and egg shell thickness was improved when these hens were supported with methionine 
in feed. 
 Poultry feed contains insufficient amounts of methionine which can lead to physiological 
and production problems in birds. Currently methionine is produced from chemical processes or 
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protein hydrolysis and used as a supplement in poultry feed.  Synthetic methionine is expensive 
and soon will no longer be allowed in organic poultry feed production (Kalbande et al., 2009).  
Therefore, a natural alternative needs to be found for methionine supplementation in poultry 
feed.   Methionine over-producing microorganisms may be an inexpensive source of natural 
methionine for the poultry industry.  
Isolaton of high content methionine containing yeasts 
C. utilis is widely used as a single cell protein for animal feed (Demain et al., 1998); 
however, in this study this organism was unable to grow in minimal medium. Only Sac. 
cerevisiae ATCC4126 and C. kefyr ATCC2512 grew under these conditions and most yeast 
strains in collection were unable to produce detectable methionine.  
Yeasts are heterotrophs and the presence of yeasts depends on their available substrates 
in habitats. In nature, yeasts are ubiquitous in aquatic, terrestrial, and airborne environments 
(Yarrow, 1998). Agricultural soils may have 40,000 viable yeasts per gram (Walker, 1998). 
Three strains originated from soil samples and the results showed that yeasts in agricultural soils 
were abundant. However, no more than one yeast strain was isolated from each soil sample. In a 
particular habitat, the number of yeast species was found to be between one to four (Phaff and 
Starmer, 1980). By screening yeasts with ethionine and norleucine, strains K1 and C1 may be 
capable of over-producing methionine since both showed more tolerance to ethionine and 
norleucine than others.  
Methionine quantification 
Methionine detection methods have been developed by using chemical and biological 
means. For example, Pediococcus acidilactici ATCC8042 was employed as a biological 
approach to methionine detection (Steele et al., 1949). However, the methionine assay medium 
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for P. acidilactici ATCC8042 is commercially unavailable and medium preparation is laborious. 
In addition, trace amounts of methionine can cause an error results. When a chemically generated 
E. coli methionine auxotroph (ATCC 23798) was used, Froelich et al. (2002) observed no 
differences based on substrate affinities of an E. coli methionine auxotroph to methionine and 
methionine hydroxy analog, respectively. Estimated maximum growth rate of the E. coli 
auxotroph when grown on both substrates was also found to be similar. To avoid problems as 
mentioned above, in this study partial metC deletion was constructed from wild-type E. coli K12. 
Without methionine supplement at 1 µg/ml, this mutant was unable to grow. The method based 
on partial metC deletion in E. coli K12 in this study was simple and based on this assay the 
lowest detectable concentration was 5 µg/ml.  
Methionine content in yeasts 
Since the yeast does not usually excrete amino acids into the culture medium (Tani et al., 
1988), only intracellular methionine amounts were determined. Compared to lactose medium, 
minimal medium enhanced the growth of both strains. It is possible that glucose as a sugar 
substrate on minimal medium may support the growth better than lactose on lactose medium. By 
culturing kefir grains with various sugar substrates, Harta et al. (2004) reported glucose as the 
substrate that yielded greater biomass compared to cultures grown on lactose.  
Yeast biomass in this study was between 0.16 to 1.46 g/L. It is possible that strains K1 
and C1 produced sufficient ethanol at levels to be somewhat inhibitory and thus cause a decrease 
in biomass syhthesis compared to previous studies. Gallardo et al. (2011) and Shin et al. (2002) 
detected ethanol during I.  orientalis fermentation. The biomass in yeasts was varied from 0.3 up 
to 10.4 g/L (Dunyak and Cook, 1985; Kitamoto and Nakahara, 1994; Tani et al., 1988). 
However, under optimal conditions, Shin et al. (2002) produced 34.5 g/L of I. orientalis.  
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The amount of methionine produced by yeast strain K1 in this study is similar to the 
results reported in the previous investigations for some yeast strains (Table 6.3). However, 
methionine biosynthesis in yeasts has been reported to vary between 1.69 to 16.02 g/g dry wt. 
Also, the biomass yields in various yeast strains were reported from 0.27 to 38.5 mg dry cell 
wt/ml. The methionine biosynthesis and biomass production possibly depend on yeast strains and 
culture conditions. By culturing yeast Candida boidinii No. 2201, one study could achieve 
methionine biosynthesis up to 16.02 mg/g dry cell wt (Tani et al., 1988) while another study 
reported methionine production was between 5.86 to 10.16 m/g dry cell wt (Lim and Tani, 
19888). In addition, yeast strains were able to tolerate methionine analogs at 0.5% (w/v). 
Kluyveromyces lactis that produced methionine at 14.15 mg/g dry cell wt, also grew under 2% 
(w/v) of ethionine. Lukondeh et al. (2003) concluded that methionine was one of the primary 
amino acids in Kluyveromyces marxianus and Sac. cerevisiae and the methionine concentrations 
were between 1 to 4 mg per g dry weight of cells. 
NRC (1994) recommends methionine requirement at 0.5 and 0.38% in broiler starter feed 
and white-egg laying hen feed. Based on broiler starter feed (NRC, 1994) and white-egg laying 
hen feed (Narvaez-Solarte et al., 2005), methionine supplement requires 170 and 140 mg per 100 
g feed, respectively. Therefore, yeast dry wt would have to be added 8.81 and 7.25 g per 100 g of 
broiler start feed and white-egg laying hen feed, respectively, to meet the methionine 
requirement.   
I. orientalis and P. kudriavezevii have been isolated from raw milk (Chen et al., 2010 a 
and b). I. orientalis usually found in fermented dairy products including kefir (Bai et al., 2010; 
Latorre-García et al., 2007; Ongol and Asano, 2009). Bai et al. (2010) reported that I. orentalis 
population was between 4 to 11% of total isolated yeast from cow, yak, goat, and camel milk. 
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I. orientalis and P. kudriavzevii are recognized as a “generally recognized as safe” 
(GRAS) organism and exhibits probiotic abilities (Chen et al., 2010b; Yao et al., 2010). In 
addition, previous studies have demonstrated the benefits of I. orientalis and P. kudriavzevii as 
probiotics. By inoculating the mixture of I. orientalis, Aspergillus sp., and Bacillus sp. in black 
soybeans, antioxidant and free radical scavenging activities in the fermented product increased 
(Yao et al., 2010). In addition, I. orientalis has been used as commercial product for animal feed 
(Koh and Suh, 2009). Broiler chicks fed with 0.25% rice bran fermented with Bacillus subtilis 
and I. orientalis exhibited higher immunity to against a virulent strain of Newcastle disease virus 
than broilers supported with Avilamycin (Koh and Suh, 2009).  
Chen et al. (2010b) proposed that P. kudriavzevii might be a potential probiotic in human 
intestine since it can assimilate cholesterol and in chickens (Garcia-Hernandex et al. 2012. 
doi:10.1016/j.rvsc.2011.09.005). This organism was isolated from broiler excreta and exhibited 
the ability to agglutinate Listeria monocytogenes, Salmonella enterica subsp. enterica serovar 
Typhimurium, and Enterococcus faecalis which could be a mechanism to support animals to 
resist pathogen establishment.  
For several decades yeast cells have been used as single cell proteins because these 
organisms grow rapidly and the protein contents are generally high (7 to 12 % nitrogen on a dry 
wt basis) (Kihlberg, 1972). In addition to being a protein source in animal feed, yeast cells are 
also rich sources of B vitamins (Kihlberg, 1972). Yeast hydrolysate has been used as the sole 
source of nitrogen in the diet in chicken and rat experiments (Gitler et al., 1958; Rastogi and 
Murti, 1961). Yeast supplied diets have been used as chicken feed; however, methionine had to 
be added (Gitler et al., 1958). 
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From an economic aspect, it is possible to culture strain K1 from various agro-industrial 
wastes. Harta et al. (2004) proposed producing kefir grains wastes to add value to wastes and 
reduce pollution. Choi et al. (2002) used waste Chinese cabbage (Brassica campestris) as a 
substrate for yeast biomass production.  The advantage of kefir cultured in bioreactor is the 
ability to form granules (Koutinas et al. 2005). When harvesting kefir biomass, only supernatant 
removal without a centrifugation step would be required. In addition, the production cost for 
making wet kefir was 1.4 Euro per kg (Koutinas et al., 2010). From a technology aspect and 
economical feasibility, strain K1 has potential for use as a supplement or probiotic in the poultry 
industry.  
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Fig.6.1 The growth of yeast strain K1. This strain was cultured on minimal medium containing 
either ethionine or norleucine at 0.5% (w/v). Strain K1 isolated from Caucasian kefir grains. 
a.b,cMeans within the same growth measurements with unlike superscripts (P < 0.05). Error bars 
indicate standard deviations between growth measurements. 
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Fig.6.2 The growth of yeast strain Sac. cerevisiae ATCC4126. This strain was cultured on 
minimal medium containing either ethionine or norleucine at 0.5% (w/v). a.b,cMeans within the 
same growth measurements with unlike superscripts (P < 0.05). Error bars indicate standard 
deviations between growth measurements. 
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Fig.6.3 The growth of yeast C. kefyr ATCC2512. This strain was cultured on minimal medium 
containing either ethionine or norleucine at 0.5% (w/v). a.b,cMeans within the same growth 
measurements with unlike superscripts (P < 0.05). Error bars indicate standard deviations 
between growth measurements. 
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Fig.6.4 The growth of yeast strain C1 isolated from a cantaloupe sample. This strain was cultured 
on minimal medium containing either ethionine or norleucine at 0.5% (w/v). a.b,cMeans within 
the same growth measurements with unlike superscripts (P < 0.05). Error bars indicate standard 
deviations between growth measurements. 
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Fig.6.5 The growth of yeast strain S1 isolated from a soil sample. This strain was cultured on 
minimal medium containing either ethionine or norleucine at 0.5% (w/v). a.b,cMeans within the 
same growth measurements with unlike superscripts (P < 0.05). Error bars indicate standard 
deviations between growth measurements. 
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Fig.6.6 The growth of yeast strain S2 isolated from a soil sample. This strain was cultured on 
minimal medium containing either ethionine or norleucine at 0.5% (w/v). a.b,cMeans within the 
same growth measurements with unlike superscripts (P < 0.05). Error bars indicate standard 
deviations between growth measurements. 
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(g) 
Fig.6.7 The growth of yeast strain S3 isolated from a soil sample. This strain was cultured on 
minimal medium containing either ethionine or norleucine at 0.5% (w/v). a.b,cMeans within the 
same growth measurements with unlike superscripts (P < 0.05). Error bars indicate standard 
deviations between growth measurements. 
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Fig. 6.8. The growth of yeast strain K1 and C1 cultured on lactose medium (LM) and minimal 
medium (MM) at 30 oC, 200 rpm. The growth measurements were measured at 580 nm and were 
performed with at least three independent cultures. Error bars indicate standard deviations 
between growth measurements. 
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Fig. 6.9. Phylogeny of partial LSU rRNA sequences from the K1 isolate and several closely 
related yeast species identified by BLAST search. Sequences harvested from GenBank are 
followed by accession numbers in brackets. The scale represents the nucleotide substitution rate. 
This Neighbor Joining tree is midpoint rooted.  
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Fig. 6.10. Standard curve generated by E. coli K12C cultured on MCGC media 
supplemented by a dilution series of L-methionine. The mean values and standard deviation of 
OD600 were performed from triplicates within the same run. 
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Table 6.1. Yeast strains used in this study. 
Yeast species/strain 
 
Source  
Schizosaccharomyces pombe ATCC26192 
 
Professor Ines Pinto, University of Arkansas 
Saccharomyces (Sac.) pastorianus 
 
Professor Ines Pinto, University of Arkansas 
Sac. cerevisiae HAO 
 
Professor Ines Pinto, University of Arkansas 
Sac. cerevisiae ATCC 90607 
 
Professor Ines Pinto, University of Arkansas 
Sac. cerevisiae ATCC 4126 
 
Professor Ines Pinto, University of Arkansas 
Candida kefyr ATCC2512 
 
Professor Ines Pinto, University of Arkansas 
Kluyveromyces marxianus ATCC16045 
 
Professor Ines Pinto, University of Arkansas 
Schizosacharomyces (Sch.) octosporus Professor Ines Pinto, University of Arkansas 
Sch. ellip 
 
Professor Ines Pinto, University of Arkansas 
C. utilis 
 
Professor Ines Pinto, University of Arkansas 
Torulaspora delbrueckii ATCC20100 
 
Professor Ines Pinto, University of Arkansas 
K1 
 
Caucasian kefir grains 
Y1 
 
Air-trapped yeast sample 
C1 
 
Cantaloupe sample 
S1 
 
Soil sample 
S2 
 
Soil sample 
S3 
 
Soil sample 
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Table 6.2. Media used in this study. 
 Minimal mediuma 
(per L) 
 
Lactose mediumb 
(per L) 
MCGC mediumc 
(per L) 
Glucose  20 g   10 g 
Lactose  20 g  
KH2PO4 0.5 g 4 g 3 g 
Na2HPO4   6 g 
NaCl   1 g 
MgSO4.7H2O 0.5 g 2 g 200 mg 
(NH4)2SO4 1 g 5 g 4 g 
CaCl2.2H2O 0.3 g  56 mg 
Yeast extract  2 g  
ZnCl2 70 ug   
H3BO3 10 ug   
MnCl2 10 ug   
MnSO4.2H2O   2 mg 
CuSO4 10 ug   
CuCl2.2H2O   0.2 mg 
FeSO4 10 ug  20 mg 
FeCl3   2 mg 
(NH4)6Mo7O24.4H2O 10 ug   
ZnSO4.7H2O   0.5 mg 
D-biotin  0.1 ug  1 mg 
Thaimin HCl   10 mg 
 
a Minimal medium (Morzycka et al., 1976) 
b Lactose medium (Lukondeh et al., 2003) 
c MCGC medium (von der Osten et al., 1989) 
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Table 6.3. Biomass and methionine concentrations in yeast samples 
 Biomass (mg dry cell 
weight/ml) a 
Methionine 
concentration (mg/g  
dry cell weight)b 
 
Reference 
K1 in lactose medium  
 
0.2142 ± 0.0321 9.2562 ± 0.7307f This study 
C1 in lactose medium 
 
0.1567 ± 0.0705 NDc This study 
K1 in minimal 
medium 
 
1.4658 ± 0.1874 19.3037 ± 0.1975d This study 
C1 in minimal 
medium 
 
1.3763 ± 0.0831 15.2984 ± 0.0837e This study 
Sac. uvarum 
 
NRg 6.2  Brigidi et al. (1988) 
Candida petrophilum 
 
NR 12.9 Komatsu et al. (1974) 
Kluyveromyces lactis 
 
8.5 to 9.5 14.15 Kitamoto and 
Nakahara (1994) 
 
Candida utilis 
 
0.27 3.7 to 4.5 Dunyak and Cook 
(1985) 
 
Candida boidinii 
 
1.7 to 3.6 16.02 Tani et al. (1988) 
Sac. lipolytica 
 
NR 1.7 Morzycka et al. 
(1976) 
 
Candida boidinii 
 
38.5h 5.86 to 10.16 Lim and Tani (1988) 
a The mean of dry cell weight mg per ml culture and standard deviations 
b The mean of methionine concentration mg per g dry cell weight and standard deviations. 
c ND, not detected 
d,e,f Means within the same columns with unlike superscripts differs (P < 0.05) 
g  not reported 
h under optimal conditions 
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CHAPTER SEVEN 
CONCLUSION AND FUTURE RESEARCH 
 
 Bifidobacterium linoleic acid isomerase LAI genes were successfully cloned into E. coli 
BL21 (DE3); however, the proteins formed inclusion bodies and no activities were detectable. 
Possibly, enzyme was an inactive form or activity was very low. Fusion between 
Priopionibacterium acnes LAI with prepropeptide Staphylococcus hyicus lipase was successful 
when this structure was expressed in Bacillus megaterium YYBm1. Unfortunately, the 
propeptide still attached with the secreted P. acnes LAI and could impede enzymatic activity. 
Conversely, prepropeptides of B. subtilis nprE, B. subtilis amyE, B. megaterium nprM did not 
protect P. acnes LAI from proteolytic degradation. Therefore, other hosts deleted intracellular 
proteases may need to be considered 
Many bacteria isolated from natural environments appeared to overproduce methionine; 
however, all of them were subsequently identified as pathogens. In addition, bacteria excreted 
methionine into the surrounding medium and it is impractical to recover methionine. Thus, it 
might be better to concentrate on isolating only specific bacterial groups such as those occurring 
in yoghurt and starter culture producers. Conversely, isolated yeast strain K1 exhibited high 
methionine content, compared to other yeasts. Based on large subunit rRNA sequencing, these 
isolated strains were identified as Pichia kudriavzevii/Issatchenkia orientalis. P. kudriavzevii/I. 
orentalis is recognized as a ″generally recognized as safe″ (GRAS) organism. Yeast strain K1 
may be suitable as a source of methionine for dietary supplements in organic poultry feed. 
 
 
